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SYNOPSIS 
 
 
Embryonic stem (ES) cell biology has become a very interesting field for scientific 
research in recent years. This is not only due to the meanwhile relatively easy 
propagation of stem cells in culture, but mainly to their very specific features, which 
offer a wide variety of research perspectives and future therapeutic approaches. 
ES cells are undifferentiated, pluripotent cells, meaning that an individual cell has the 
capability to differentiate into all cell types of a mammalian body. The possibility to 
differentiate ES cells in vitro into specific lineages provides an opportunity to follow up 
differentiation processes and reveal factors involved in the generation of specific 
progenitors or committed cell types. With human ES cells, there is a strong effort to use 
this knowledge for cell replacement therapies to repair damaged organs or as vehicle 
for drug delivery to specific sites within the body. In addition, such studies can provide 
further understanding of embryogenesis without the use of transgenic animals. 
The pluripotency of stem cells depends on their ability to self-renew. Self-renewal is the 
ability to proliferate via symmetrical cell divisions without differentiation, therefore 
ensuring identical pluripotent progeny. 
Another specific feature of ES cells is their rapid proliferation rate together with unusual 
cell cycle kinetics, which is speculated to be as well related to self-renewal and the 
maintenance of pluripotency (Burdon et al., 2002; Niwa, 2007). In culture, ES cells show 
an unlimited proliferation potential although they are derived without addition of any 
immortalizing agent (Suda et al., 1987). Moreover, ES cells do not undergo 
senescence, do not show contact inhibition, and can grow without the addition of serum, 
properties also typical of tumor cells. When introduced into somatic tissues, ES cells 
show indeed tumorigenic potential, which might interfere with their usage for therapeutic 
purposes (Takahashi et al., 2003a). Studying the unusual proliferation properties of ES 
cells is therefore an important issue that might also advance our understanding of 
transformed cells and of the self-renewal process. 
 
Proliferation is a coordinated process between cell growth and cell division. This tight 
balance is necessary to prevent cells from premature division. In ES cells, which lack 
some of the usual control points during the cell cycle, not much is known about a 
possible coordination between these processes. One important regulator of cell growth 
is ribosome biogenesis, which has recently been linked to cell cycle pro gression. As a 
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factor, involved in both processes, the PeBoW-complex has been identified. The 
components of the PeBoW-complex, Pes1, Bop1 and WDR12 have been shown to be 
necessary for maturation of the large ribosomal subunit and for cell proliferation in 
mature cell systems. Disruptions in ribosome synthesis, following depletion of the 
PeBoW-complex, are proposed to be transmitted to the cell cycle machinery via a p53- 
dependent checkpoint response (Holzel et al., 2005; Pestov et al., 2001). During this 
work it was investigated whether Pes1, Bop1 and WDR12 have an effect on 
proliferation of embryonic stem cells and how ribosome biogenesis and proliferation are 
coordinated in stem cells. 
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1 INTRODUCTION   
 
 
1.1 Mouse embryonic stem cells  
 
The hallmark of stem cells, embryonic or adult, is their capacity for self-renewal on one 
hand and differentiation on the other hand. Embryonic stem cells are pluripotent and 
represent the origin of all tissues of the mammalian body. Pluripotency is generally 
defined as the ability to give rise to derivatives of all three germ layers and germ cells; 
that is, essentially all cell types, found in an adult organism (Boiani and Scholer, 2005; 
Solter, 2006). In contrast, adult stem cells are further developed and therefore 
considered as multipotent. They can give rise only to a restricted number of specific cell 
types within the body, e.g., hematopoietic stem cells can differentiate into the different 
types of blood cells. Adult stem cells play an important function within the body for 
replacement of aging or damaged tissues. But not for all tissues exist adult stem cells 
that can renew them after injury. Therefore, research on embryonic stem cells is 
expected to provide a promising tool for regenerative medicine. 
During early embryonic development, the totipotent zygote develops via blastomeres 
into the morula, a stage of about 100 cells at day 2-3 post fertilization. The morula 
gradually reorganizes and expands to give rise to the blastula. At this stage, 
differentiation events partition the embryo into the outer trophectoderm, which will later 
form the placenta, and the inner cell mass (ICM), the embryonic component. With 
further development of the mouse, the ICM gives rise to two distinct lineages: the 
extraembryonic (or primitive) endoderm, which will form extraembryonic tissues, and the 
epiblast, which gives rise to the embryo proper (via primitive ectoderm) (Niwa, 2007).  
Mouse embryonic stem cells are isolated from the inner cell mass (ICM) of the 
blastocyst from 3-4 day old preimplantation embryos (Evans and Kaufman, 1981; 
Martin, 1981). Under addition of the cytokine LIF (leukemia inhibitory factor), mouse ES 
cells can be propagated in culture unlimited, without loosing their self-renewal 
properties. LIF can be provided by secretion from feeder cells or, alternatively, it can be 
added as a recombinant protein into the medium, bypassing the need for feeder cells 
(Smith et al., 1988; Williams et al., 1988). Withdrawal of LIF from cultivation medium 
leads to differentiation of ES cells in vitro. When ES cells are reintroduced into a 
blastocyst, they can contribute to all cells of the embryo proper.  
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In principal, ES cells represent an in vitro counterpart of a cell population from the early 
embryo, the ICM. Nevertheless, the cell population of the ICM exists only for a limited 
time and then differentiates into the fetus and finally the adult organism. It is presumed 
that ES cells are a transient population that can be maintained practically indefinitely in 
vitro through selection and adaptation to the culture environment (Buehr and Smith, 
2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Isolation, cultivation and differentiation of mouse embryonic stem cells. During early 
embryonic development, the fertilized, totipotent oocyte develops via the morula and blastocyst 
stages into the fetus. During the early blastomere stages all cells are totipotent, while the blastocyst 
contains pluripotent cells (the inner cell mass - ICM) and surrounding trophectoderm. Pluripotent 
embryonic stem cells are isolated from the ICM of a blastocyst. Under addition of leukemia inhibitory 
factor (LIF), mouse ES cells can be cultured in vitro unlimited without loosing their self-renewal 
properties. In the absence of LIF, they can differentiate into specific cell types like blood cells, nerve 
cells etc. (Figure was obtained and modified from http://www.biokurs.de/skripten/bs11-76.htm) 
 
 
1.1.1 Self-renewal of mouse embryonic stem cells 
 
Self-renewal describes the capacity of ES cells to divide without differentiation, so that 
they remain pluripotent. A variety of pathways are involved in this process. One 
important factor for the maintenance of pluripotency of mouse ES cell lines in vitro is the 
leukemia inhibitory factor (LIF), which belongs to the interleukin-6 cytokine family. LIF 
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signals through a heterodimeric receptor complex, consisting of gp130 and LIF receptor 
(LIFR). By binding of LIF, this complex activates associated JAK kinases (Janus 
associated tyrosine kinases), which phosphorylate gp130 and LIFR on tyrosine 
residues. This in turn leads to recruitment and tyrosine phosphorylation of STATs 
(signal transducer and activator of transcription), predominantly STAT3, by JAKs. 
Phosphorylation leads to dimerization and translocation of STAT3 dimers into the 
nucleus, where they control transcription of genes regulating self-renewal. STAT3 
activation is essential and sufficient to maintain pluripotency (Matsuda et al., 1999; Niwa 
et al., 1998). Recently, c-Myc has been identified as one of the major targets of STAT3, 
involved in self-renewal. Sustained c-Myc activity could maintain ES cell self-renewal in 
the absence of LIF, while overexpression of a dominant negative mutant promoted 
differentiation (Cartwright et al., 2005). 
Additionally to STAT3, LIF induces other signaling proteins including PI3K 
(phosphoinositide 3-kinase), Src family tyrosine kinases, and ERKs (extracellular signal-
regulated kinases) via the MAPK (mitogen-activated protein kinase) pathway (Anneren 
et al., 2004; Burdon et al., 1999). Src and PI3K activation have been reported to support 
self-renewal. Inhibition of PI3K with specific inhibitors led to a differentiated morphology 
and reduced basal and LIF-stimulated phosphorylation of protein kinase B (PKB or Akt), 
glycogen synthase 3 (GSK-3) α/β and ribosomal S6 proteins and elevated LIF induced 
ERK activity (Paling et al., 2004). Furthermore, a myristoylated, active form of Akt 
maintained the undifferentiated phenotype of mouse ES cells without the addition of 
LIF. This was independent of the Wnt/β-catenin pathway, supporting the role for 
PI3K/Akt signaling in self-renewal (Watanabe et al., 2006). In contrast, activation of 
ERKs leads to differentiation. Apparently, the balance between LIF induced STAT3 plus 
the other pro self-renewal pathways and ERK signaling is important for the decision of 
self-renewal versus differentiation (Burdon et al., 2002). SOCS3 (suppressor of cytokine 
signaling) is also involved in the regulation of self-renewal. Its expression is stimulated 
by LIF. Overexpression of SOCS3 inhibits the JAK/STAT pathway, thereby regulating 
LIF signaling in a negative feedback loop. Low expression amounts instead attenuate 
Shp2-dependent MAPK signaling (Duval et al., 2000; Schmitz et al., 2000). 
For efficient self-renewal, LIF signaling needs to collaborate with other factors usually 
present in the serum added to the culture medium. For example, bone morphogenetic 
factors (Bmps) have been shown to work in collaboration with LIF. Bmp2 and Bmp4 
promote self-renewal in the presence of LIF via upregulation of Ids (inhibitors of 
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differentiation), which suppress genes involved in neuronal development, and via 
inhibition the p38 and ERK MAP-Kinase activities (Qi et al., 2004; Ying et al., 2003).  
Moreover, a range of transcription factors, the most intensively studied being Nanog, 
Sox2 and Oct4, play an important function (Chambers et al., 2003; Mitsui et al., 2003; 
Pesce and Scholer, 2001). They seem to build a self-organizing network that prevents 
differentiation and promotes self-renewal and might also be involved in epigenetic 
processes, which are important for pluripotency (Niwa, 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Schematic model of the main pathways involved in self-renewal of mouse 
embryonic stem cells. A detailed description is given in chapter 1.2.1.  
 
 
The canonical Wnt pathway seems to have a major function in self-renewal of mouse 
and of human ES cells, where LIF signaling does not play a role. Wnt factors act 
through their receptors called Frizzled, leading to stabilization of β-catenin via blocking 
of glycogen synthase kinase-3β (GSK-3β). Activation of the Wnt signaling by BIO, a 
pharmacological inhibitor of GSK-3, maintained an undifferentiated phenotype in mouse 
and human ES cells and sustained the expression of transcription factors like Oct4 and 
Nanog, involved in the maintenance of pluripotency (Sato et al., 2004). Recently, it has 
been shown that activation of the Wnt pathway also upregulates the mRNA of STAT3, 
suggesting a synergistic effect with LIF signaling (Hao et al., 2006). Moreover, as Wnt 
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signaling has been reported to activate transcription of c-Myc in certain cell-types and c-
Myc has been shown to be a target of STAT3, it was supposed that LIF- and Wnt 
signaling may converge on c-Myc as a common target to promote self-renewal 
(Cartwright et al., 2005). Recent data suggest though that in human ES cells sustained 
activation of c-Myc rather leads to apoptosis and differentiation (Sumi et al., 2007).  
High telomerase activity is another feature of ES cells, which is related to self-renewal 
and indefinite replication. Telomerase is a ribonucleoprotein that is involved in 
maintaining telomere length by adding telomere repeats to the chromosome ends. This 
plays an important role in chromosome integrity and replicative lifespan (Armstrong et 
al., 2000; Thomson et al., 1998). Interestingly, the promoter of the catalytic subunit of 
telomerase (TERT) contains c-Myc binding sites, further approving a role for c-Myc in 
self-renewal.  
In addition, the high proliferation rate and the specific features of the cell cycle of ES 
cells (see 1.3.2) are also presumed to be involved in the maintenance of pluripotency 
(Burdon et al., 2002; Niwa, 2007). Interestingly, pathways like PI3K signaling show an 
overlapping function for both processes. 
Finally, the chromatin state and epigenetic modifications play an important role in ES 
cell pluripotency in determining gene activity. The chromatin of ES cells is different from 
somatic cells, including nuclear architecture, chromatin structure and dynamics, and 
histone modifications. The chromatin of ES cells displays for instance characteristics of 
loosely euchromatin, such as an abundance of acetylated histone modifications (Boyer 
et al., 2006; Meshorer and Misteli, 2006). 
Interestingly, recent data indicate that somatic cells can be reprogrammed in vitro into a 
pluripotent, ES cell-like state (Takahashi and Yamanaka, 2006; Wernig et al., 2007). 
Reprogramming of fibroblast could be induced by ectopic expression of the transcription 
factors Oct4, Sox2, c-Myc and Klf4. DNA methylation, gene expression and chromatin 
state of the induced, reprogrammed cells was similar to those of ES cells (Wernig et al., 
2007). 
 
 
1.1.2 Differentiation of mouse embryonic stem cells 
 
When cultured without addition of LIF, ES cells differentiate spontaneously. On non-
adhesive substrates they form spheroid cell aggregates, termed embryoid bodies (EBs) 
because of their resemblance to post-implantation embryos (Doetschman et al., 1985; 
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Leahy et al., 1999). The differentiation processes within EBs strongly resemble the 
processes taking place in a post-implantation embryo, leading to differentiation via 
derivatives of the three germlayers of ecto-, endo-, and mesoderm into more mature 
progenitors and committed cell types like cardiomyocytes, endothelial cells, neuronal 
cells and others. Although multiple cell types form within the EBs, the differentiation 
appears to be largely unpatterned compared to the precise organization within the early 
embryo (O'Shea, 2004).  
In principle, ES cells are also able to differentiate as a monolayer, but the three-
dimensional structure of EBs has the advantage to enhance cell-cell interactions, which 
may be required for certain developmental programs (Keller, 2005). To favor 
differentiation of distinct lineages, a variety of different protocols with specific 
supplements have been established that allow differentiation into almost any cell type. 
Moreover, ES cells are relatively easily amenable to genetic alterations. Thus, in vitro 
differentiation of ES cells via EB formation provides a tool to study certain aspects of 
mouse embryogenesis more rapidly and without the generation of knockout mice. 
In the pluripotent state, ES cells show rapid proliferation rates due to unusual cell cycle 
properties with short gap phases and with most cells being in the S-phase (see 
chapter 1.3.2). When ES cells start to differentiate, the G1-phase becomes longer and 
proliferation slows down (White et al., 2005). This goes along with changes in the cell 
cycle machinery, which is adapting to the “normal” state, known from mature cells. 
 
 
1.2 Proliferation and cell cycle 
 
Cell proliferation requires a tight coordination between cell growth and cell division to 
prevent cells from premature division and loss of size (Polymenis and Schmidt, 1999; 
Thomas, 2000). Coordination of these processes takes place primarily during the cell 
cycle, which the cells pass during their proliferative stage. The cell cycle can be divided 
into four different phases. The G1- (gap1) phase is characterized by high biosynthesis 
and cell growth, during the S- (synthesis) phase DNA replication takes place, in G2- 
(gap2) phase the cell continues to grow and gets ready for mitosis and during the M- 
(mitosis) phase the cell divides, leading to transmission of the genetic information from 
one cell-generation to the next. Transition of cells through the cell cycle is driven by 
subsequent activation of distinct cyclin-dependent kinases (Cdks). The activity of Cdks 
is regulated via binding of cyclins and by their phosphorylation state. Each cell cycle 
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phase is characterized by the expression of distinct cyclins, which in turn activate the 
respective Cdks (Obaya and Sedivy, 2002). An overview about the cyclin/Cdk 
complexes, which are active during the different cell cycle phases, is given in table 1. 
Several checkpoints during the cell cycle (G1-, G2- and M-checkpoint) assure 
coordination and completion of the processes important to each phase. One important 
checkpoint, regulating the coordination between cell growth and cell division in mature, 
mammalian cells, is the G1- or G1/S-phase checkpoint. 
 
 
Cell cycle phase Cyclins Respective Cdks 
G1-phase cyclin D1, D2, D3 Cdk4, 6 
G1/S-phase cyclin E Cdk2 
S-phase cyclin A Cdk2 
G2-phase cyclin A Cdk1 
M-phase cyclin B Cdk1 
 
Table 1: Overview about the cyclin/Cdk complexes, which are active during distinct cell cycle 
phases in mammalian cells. 
 
 
1.2.1 Cell cycle and G1/S-phase checkpoint of mature cells 
 
During early G1-phase the decision is made whether a cell will proliferate and activate 
the cell cycle or whether it will exit the cycle and go into a quiescent state, the G0-
phase. To enter the cell cycle, the availability of mitogenic stimuli from the environment 
is essential and the cell has to pass the restriction point to be able to enter S-phase.  
Mitogenic signaling in early G1-phase usually leads - depending on the cell type - to 
activation of the MAPK pathway and c-Myc and finally to expression of D-type cyclins 
(D1, D2, D3) and Cdk4 and Cdk6 (Aktas et al., 1997; Bouchard et al., 1999; Ekholm 
and Reed, 2000; Lavoie et al., 1996; Perez-Roger et al., 1999). Subsequent association 
of cyclin D with Cdk4 and Cdk6 leads to phosphorylation and activation of the Cdks, 
which in turn phosphorylate the retinoblastoma protein (Rb) (Bates et al., 1994; Kato et 
al., 1993). Rb can be called the gatekeeper of cell cycle. It belongs, together with its 
relatives p107 and p130, to the so called pocket proteins, whose functions show partial 
redundancy. Their phosphorylation state plays an essential role for the transition from 
G1- to S-phase by sequestering the E2F family of transcription factors, which are 
required for the expression of S-phase entry genes. Hypo-phosphorylated Rb blocks 
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E2F and therefore S-phase entry in quiescent cells and early G1-phase. During G1-
phase Rb is partially phosphorylated by cyclinD/Cdk4 and cyclinD/Cdk6 complexes, 
which leads to a partial release of E2F, sufficient to activate transcription of its target 
genes cyclin E and cdc25a. The phosphatase cdc25a removes inhibitory phosphates 
from Cdk2 and the resulting cyclinE/Cdk2 complex then completes Rb phosphorylation, 
leading to full release of E2F, expression of its target genes and therefore entry into S-
phase (Harbour and Dean, 2000; Helin et al., 1993; Weinberg, 1995). In parallel, the 
cyclinE/Cdk2 complex is involved in S-phase progression by regulation of factors 
involved in DNA replication like histone biosynthesis (Zhao et al., 2000). The point 
where Cdk2 is elevating its own activity in a positive feedback loop via Rb is called the 
restriction point. At this “stage of no return” the cell has to fully complete the cycle, 
independent of mitogenic signals (Blagosklonny and Pardee, 2002). In parallel to the 
Rb/E2F pathway, c-Myc also has a function in passing the restriction point by regulating 
the expression of cyclinE and cdc25a (Bartek and Lukas, 2001; Santoni-Rugiu et al., 
2000). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Schematic model of the G1/S-phase checkpoint in mature mammalian cells. Rb is 
called the gatekeeper of the cell cycle. In the active (hypo-phosphorylated) state Rb blocks the 
transition of cells from G1-phase into S-phase by binding the E2F family of transcription factors, 
which are essential for S-phase entry. In case of mitogenic stimulation cyclinD/Cdk4 and 
cyclinD/Cdk6 complexes are activated, which leads to partial phosphorylation of Rb and thus to 
partial release of E2F and transcription of their target genes, one of which is cyclin E. This leads to 
activation of cyclinE/Cdk2 complexes, which further phosphorylate and inactivate Rb, leading to full 
release of E2F transcription factors, transcription of their target genes and entry into S-phase. On the 
other hand, cellular stress can inhibit transition of cells into S-phase by blocking cyclinE/Cdk2 activity 
via the Cdk-inhibitor p21, which is regulated by the tumor suppressor p53. Alternatively, p53 can 
induce apoptosis. 
Introduction 
11 
In contrast to mitogenic signals, which lead to S-phase entry and proliferation, cellular 
stresses are involved negatively in the regulation of G1/S-phase transition. Cellular 
stress like DNA damage usually leads to induction of the tumor suppressor p53, which 
activates expression of the Cdk-inhibitor p21, which in turn targets Cdk2 and Cdk4/6 
(Harper et al., 1995; Vogelstein et al., 2000). Inhibition of the kinase activities prevents 
phosphorylation of Rb and therefore arrests the cells in G1-phase. In addition to a G1-
arrest, p53 can also mediate apoptosis. The decision between the two processes is 
dependent on the overall condition of the cell, e.g., extreme DNA damage, which cannot 
be repaired during a prolonged G1-phase, would favor the apoptotic pathway. 
In addition to p21, other CDK inhibitors can regulate cell cycle progression. Two main 
families are known. The Cip/Kip family includes p21WAF1/CIP1, p27KIP1 and p57KIP2, which 
inhibit mainly cyclin E- and cyclin A-dependent Cdk2 activities. The INK4 family includes 
p16INK4a, p15INK4b, p18INK4c and p19ARF/INK4d, which inhibit the catalytic subunits of Cdk4 
and Cdk6. p19ARF/INK4d is involved in the regulation of the tumor suppressor p53 by 
binding to Mdm2, thereby blocking p53 degradation (Sherr and Roberts, 1999). 
 
 
1.2.2 Cell cycle of mouse embryonic stem cells 
 
Compared to mature cells, where cell cycle progression and proliferation relies on the 
balance between mitogenic signals and growth inhibitory signals, cell cycle progression 
of ES cells seems to rely more on intrinsic factors. 
One of the most striking difference between the cell cycle of ES cells and mature cells is 
that the control mechanisms for the G1/S-phase checkpoint are strongly reduced or 
absent in mouse ES cells. This goes in line with the majority of cells being in S-phase 
and a very short G1-phase of roughly 1.5 hours, which can explain the high proliferation 
potential (Savatier et al., 1994). Doubling time of mouse ES cell lines has been 
described to be around 10-15 hours. Although the pocket proteins Rb and p107 are 
expressed in ES cells, they are present almost exclusively in the inactive, hyper-
phosphorylated form and cyclinE/Cdk2 and cyclinA/Cdk2 kinase complexes seem to be 
constitutively active throughout the cycle, suggesting that the cell cycle is constitutively 
primed for S-phase entry and DNA replication (Savatier et al., 1994; Stead et al., 2002; 
White et al., 2005). In addition to cyclinE/Cdk2, which was supposed to be the main 
player in Rb phosphorylation, recently cyclinD3/Cdk6 complexes were shown to be 
robustly involved in the phosphorylation of Rb (Faast et al., 2004). Instead, 
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cyclinD/Cdk4 kinase activity is almost undetectable and seems to be dispensable for 
phosphorylation and inactivation of Rb. Despite the active cyclinD/Cdk6 complex, ES 
cells do not respond with growth arrest to overexpression of the inhibitor p16, usually 
targeting cyclinD/Cdk4/6 complexes (Faast et al., 2004; Savatier et al., 1996). 
Generally, the Cdk inhibitors p16, p21 and p27 are absent in ES cells (Fujii-Yamamoto 
et al., 2005; Savatier et al., 1996; Stead et al., 2002). Moreover, cell cycle progression 
of mouse ES cells is independent of persistent serum stimulation and of the Ras/ERK 
pathway (Jirmanova et al., 2002; Schratt et al., 2001). 
Instead, PI3K-dependent signaling plays an important function for the progression of 
mouse ES cells through G1-phase as well as for inhibition of differentiation (Jirmanova 
et al., 2002; Paling et al., 2004). Inhibition of PI3K activity by the inhibitor LY294002 led 
to an accumulation of cells in G1-phase and deletion of Pten, a negative regulator of 
PI3K, increased proliferation and viability of mouse ES cells (Sun et al., 1999). PI3K 
activity is also independent of serum stimulation, but relies on LIF stimulation. In 
addition, a stem cell specific member of the Ras family, termed Eras, which is 
constitutively active, has been shown to activate PI3K signaling (Takahashi et al., 
2003a).  Eras-null cells show impaired proliferation as well as reduced tumorigenicity 
when introduced into somatic tissues. As Eras cannot bind Raf it does not stimulate the 
MAPK pathway. Furthermore, the protein Tcl1 can increase the activity of Akt by 
forming a complex with the latter. Tcl1 could be linked to proliferation and self-renewal 
(Ivanova et al., 2006; Matoba et al., 2006).  
Interestingly, the G1/S-phase checkpoint seems to be also impaired after stress. At 
least DNA damage after irradiation seems not to induce a G1-arrest, although abundant 
quantities of p53 are synthesized (Aladjem et al., 1998; Hong and Stambrook, 2004). 
Instead, cells accumulated in S- and G2/M-phase and showed elevated apoptosis. An 
induced G1-arrest by overexpression of Chk2 kinase, whose function was shown to be 
impaired in ES cells, could protect ES cells from apoptosis. This indicates that the lack 
of a G1-checkpoint after DNA damage may favor apoptosis, thereby ensuring genome 
integrity of the ES cell population (Hong et al., 2007). Moreover, no elevated p21 levels 
were detected probably due to predominantly cytoplasmic localization of p53. Data with 
p53 deficient cells indicate a transient, p53-independent arrest in S-phase after UV 
treatment (Prost et al., 1998) and also p53-independent apoptosis was reported 
(Aladjem et al., 1998) 
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1.3 Nucleolus and cell cycle control 
 
The nucleolus, a specialized compartment within the nucleus, is another important 
factor for regulation of cell proliferation. As the site of ribosome biogenesis, the 
nucleolus has long been known to be involved in the translation capacity of a cell and 
therefore in cell growth. More recently, it has been revealed that the nucleolus is also 
directly involved in cell cycle progression. In fact, it can be considered as a major link 
between cell growth and cell division (see chapter 1.4.2). 
 
 
1.3.1 Ribosome biogenesis in mammalian cells 
 
Ribosome biogenesis is a highly complex, well-coordinated, evolutionary conserved 
process that takes place in the nucleoli (Fromont-Racine et al., 2003). Ribosomes of 
mammalian cells consist of a large 60S subunit and a smaller 40S subunit, which are 
comprised of RNA and ribosomal proteins. During ribosome synthesis, the tandem-like 
repeats of rDNA, present within the nucleolus, are transcribed by RNA Polymerase I 
(Pol I) into a large precursor ribosomal RNA (47S pre-rRNA). This polycistronic 
precursor contains the mature 18S, 5.8S and 28S rRNAs interspersed with the non-
coding internal transcribed sequences ITS1 and ITS2 and is flanked 5' and 3' by 
external transcribed spacers (ETS). The 18S rRNA will be the rRNA component of the 
40S subunit, while the 5.8S and 28S rRNAs will constitute the RNA component of the 
60S subunit, together with the 5S RNA, which is transcribed independently by RNA 
Polymerase III (Pol III). In addition, up to 80 ribosomal proteins have been identified so 
far that assemble together with the rRNAs to form the mature ribosomes (Eichler and 
Craig, 1994; Fatica and Tollervey, 2002; Warner, 1999). After transcription, the large 
precursor rRNA is rapidly assembled with ribosomal proteins, nonribosomal proteins 
and small nucleolar RNAs (snoRNAs) into a 90S pre-ribonucleoprotein particle (90S 
pre-RNP), followed by massive modification of the precursor rRNA by pseudouridylation 
and methylation. For further maturation, the primary transcript is processed via exo- and 
endonucleolytic ribonucleases to the mature rRNAs (Eichler and Craig, 1994; Venema 
and Tollervey, 1999). After cleavage within the ITS1, the 90S precursor splits into the 
pre-40S and pre-60S particles, which further mature into the 40S and 60S subunits. In 
yeast, where ribosome biogenesis is better understood than in mammals, over 150 
nonribosomal proteins and about the same amount of snoRNAs have been revealed to 
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be part of these precursor rRNPs and are putatively involved in ribosome biogenesis 
(Fatica and Tollervey, 2002; Fromont-Racine et al., 2003; Tschochner and Hurt, 2003). 
In higher eukaryotes, much less is known about the ribosome synthesis machinery. But 
proteomic analyses of the human nucleolus in the recent years suggest that many of 
the components have been evolutionary conserved (Andersen et al., 2002; Leung et al., 
2006; Scherl et al., 2002; Takahashi et al., 2003b). The general steps involved in the 
processing of rRNAs in vertebrates are comparable to those in yeast, however, as the 
ETS and ITS sequences diverge greatly between different eukaryotes, the endo- and 
exonucleolytic cleavage of the precursor rRNA can vary according to the species, cell 
type or physiological state (Eichler and Craig, 1994; Hadjiolova et al., 1993). In general, 
the processing events occur from the 5' to the 3' of the nascent transcript (Strezoska et 
al., 2000). 
Processing of the preribosomal transcripts into the mature rRNAs and assembly of the 
rRNPs mainly takes place inside the different regions of the nucleolus and later steps in 
the nucleus. Only addition of the last ribosomal proteins, a final processing step of the 
18S rRNA and the final assembly of the two subunits is completed in the cytoplasm, 
where the mature ribosomes then fulfill their function of mRNA translation (Rouquette et 
al., 2005). 
 
Ribosome biogenesis places a major energy and biosynthetic demand upon cells, 
accounting for up to 80% of the energy consumption of a proliferating cell (Thomas, 
2000; Warner, 1999). Therefore, it requires precise regulation and coordination with cell 
cycle progression. In fact, ribosome biogenesis is cell cycle controlled. It is sensitive to 
nutrient and growth factor signaling and inhibited upon stress signals (Mayer et al., 
2005; Mayer and Grummt, 2005; Mayer et al., 2004; Sirri et al., 2002; Voit et al., 1999). 
On the other hand, proper ribosome biogenesis is essential to keep p53 levels down 
and thereby ensure proliferation (see chapter 1.4.2). In this light it is not surprising that 
deregulation of ribosome biogenesis plays a role in cancer (Ruggero and Pandolfi, 
2003). 
 
 
1.3.2 Link of nucleolar disruptions and cell cycle progression 
 
The view of the nucleolus as a mere ribosome producing factory has recently been 
challenged as it became obvious that it is involved in many more processes than just 
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ribosome synthesis (Olson et al., 2000). For example, it has been suggested that the 
nucleolus is involved in the maturation of other ribonucleoprotein particles like the signal 
recognition particle and telomerase (Mitchell et al., 1999; Politz et al., 2000). In addition, 
the nucleolus can participate in export or processing of some mRNAs and tRNAs 
(Bertrand et al., 1998; Schneiter et al., 1995). Most intriguingly, a function of the 
nucleolus in cell cycle regulation via the tumor suppressor p53 has been described 
(Olson, 2004; Rubbi and Milner, 2003). p53 is a key regulator of the cell cycle that 
activates cell cycle arrest and apoptosis during cellular stress. During normal growth, 
p53 is targeted for degradation by Mdm2, an E3 ubiquitin ligase, and exported to the 
cytoplasm where it is degraded by the proteasome. Additionally, Mdm2 can bind p53, 
thereby repressing its transcriptional activity in the nucleus (Haupt et al., 1997; Kubbutat 
et al., 1997; Oliner et al., 1993). This keeps p53 levels low and cells proliferate. 
On the other hand, disturbances in ribosome biogenesis, which is highly sensitive to a 
lot of cellular stresses, have been shown to lead to an induction of p53, which triggers 
cell cycle arrest or apoptosis. Several mechanisms have been proposed about how this 
induction of p53 is mediated. First, impaired ribosome biogenesis can decrease the 
demand of ribosomal proteins and can therefore lead to accumulation of free ribosomal 
proteins such as L5, L11 or L23, which can bind and inactivate Mdm2 resulting in 
stabilization and accumulation of p53 (Dai and Lu, 2004; Dai et al., 2004; Jin et al., 
2004; Lohrum et al., 2003; Zhang et al., 2003). Another hypothesis takes into account 
that cytoplasmic p53 has been detected covalently linked to the 5.8S rRNA of a subset 
of ribosomes, suggesting that the export of p53 into the cytoplasm may depend on the 
export of intact ribosomal subunits (Fontoura et al., 1997; Sherr and Weber, 2000). 
 
The model of a crosstalk between ribosome biogenesis and cell cycle via p53 has been 
expanded by Rubbi and Milner. They propose that p53 induction after different cellular 
stresses is generally coupled to disruptions within the nucleolus (Rubbi and Milner, 
2003). They could demonstrate by micropore UV irradiation that DNA damage only 
leads to a p53 response, if the nucleolar structure is also affected. In addition, they 
linked a range of different agents inducing p53 stabilization to disruptions in the 
nucleolus, including DNA damaging agents, anticancer drugs, inhibitors of RNA 
synthesis and general stress signals like hypoxia or heat shock. These findings suggest 
that the nucleolus might function as a universal stress sensor, the disruption of which 
leads to a rapid p53-mediated checkpoint response, regulating cell cycle progression. 
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The direct crosstalk between ribosome biogenesis and cell cycle by activation of a 
critical checkpoint is one possibility for a cell to coordinate division with growth. Another 
possibility is to measure the translation capacity of a cell. Such mechanisms are known 
in yeast and drosophila (Polymenis and Schmidt, 1997; Polymenis and Schmidt, 1999; 
Thomas, 2000). In yeast, cell size is a critical parameter for the cell to pass the 
restriction point (start). To do so, the cells need a sufficient amount of the G1-Cyclin 
Cln3. As the Cln3 mRNA contains a second ORF, upstream of the Cln3 ORF, 
ribosomes bind with less efficiency to the Cln3 ORF. To reach an efficient translation of 
Cln3 mRNA, the cell has to grow first and produce enough ribosomes to translate also 
the Cln3 ORF with high efficiency to produce enough protein to finally pass the 
restriction point. So the translation efficiency of Cln3 is used as a reference for cell cycle 
regulation (Polymenis and Schmidt, 1997). 
 
In ES cells, not much is known so far about the mechanisms correlating cell growth with 
cell division. ES cells show novel regulatory pathways for proliferation, lack the normal 
G1/S-phase checkpoint and have probably an impaired p53 pathway (see chapter 
1.3.2). First experimental evidence that the nucleolus and ribosome synthesis are also 
involved in the regulation of stem cell proliferation is given by studies with the nucleolar 
protein Nucleostemin, a putative GTPase involved in p53 regulation. Depletion or 
overexpression of Nucleostemin reduced the proliferation rate of neuronal stem cells 
and of mutant blastocysts (Beekman et al., 2006; Tsai and McKay, 2002). Moreover, 
depletion of Bysl (bystin-like) a protein involved in maturation of the small ribosomal 
subunit showed impaired proliferation of embryonic stem cells (Adachi et al., 2007). 
Nevertheless, little is known about the underlying mechanisms coordinating the two 
processes. 
 
 
1.4 The PeBoW-complex 
 
The PeBoW-complex is one factor involved in the p53-mediated checkpoint response 
between nucleolus and cell cycle in mature cell systems. It has recently been 
characterized in mammalian cell lines and consists of the proteins Pes1 (pescadillo) 
Bop1 (block of proliferation) and WDR12 (WD-repeat protein) (Holzel et al., 2005; 
Rohrmoser et al., 2007). The PeBoW-complex is located within the nucleoli and it is 
involved in ribosome biogenesis, namely in the maturation of the large 60S ribosomal 
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subunit. Knockdowns of its components Pes1, Bop1 or WDR12, by expression of 
dominant negative mutants or siRNA technology, block processing of the 36/32S 
precursor rRNA into the mature 28S rRNA and 5.8S rRNA and subsequently the 
maturation of the large ribosomal subunit. Maturation of the small subunit is not affected 
(Grimm et al., 2006; Holzel et al., 2005; Strezoska et al., 2000; Strezoska et al., 2002). 
In addition, an induction of p53 could be examined, followed by a strong cell cycle arrest 
in G1-phase and an impaired proliferation rate (Grimm et al., 2006; Holzel et al., 2005; 
Pestov et al., 2001). All three proteins are upregulated by the transcription factor and 
proto-oncogene c-Myc and incorporation of the single proteins into the PeBoW-complex 
as well as nucleolar localization seem to be prerequisites for their function ((Grimm et 
al., 2006; Holzel et al., 2005; Lapik et al., 2004; Rohrmoser et al., 2007). 
The structure and function of the PeBoW-complex appears to be conserved throughout 
evolution. In yeast, a potential homolog of the PeBoW-complex has been identified, 
which is similarly involved in ribosome biogenesis and cell cycle progression. It consists 
of the proteins Nop7 (or Yph1), Erb1 and Ytm1, whose homology with the mammalian 
Pes1, Bop1 and WDR12 averages more than 40% (Du and Stillman, 2002; Miles et al., 
2005; Oeffinger et al., 2002). Similar to mammalian cells, depletion of the proteins leads 
to impaired maturation of the large ribosomal subunit (Miles et al., 2005). 
In addition to its role in ribosome biogenesis, the PeBoW-complex has been linked to 
other processes. In yeast, all three proteins have been identified as part of a bigger 
complex. Besides 66S ribosomal proteins and preribosomal particle proteins, this 
complex contained ORC and MCM proteins as well as checkpoint- and cell cycle 
regulatory proteins, indicating a role in replication and cell cycle control. For Nop7, the 
yeast homolog of Pes1, a direct involvement in replication could be proven, as its 
depletion led to an arrest of cells in G1- or G2-phase with no cells in S-phase. This 
effect was independent of impaired ribosome biogenesis (Du and Stillman, 2002). 
Moreover, the PeBoW-complex was linked to a function in mitosis as inactivation of 
Pes1 and Bop1 in human cell lines leads to abnormal mitoses with altered 
chromosomal segregation followed by chromosomal instability (CIN) (Killian et al., 
2004). As CIN is a hallmark of many tumors, this might indicate a role of the PeBoW-
complex in tumorigenesis and indeed increased expression of Bop1 could be detected 
frequently in colorectal cancers. Furthermore, overexpression of Bop1 increased the 
percentage of multipolar spindles (Killian et al., 2006). Interestingly, overexpression of 
Pes1 was reported to be involved in the transformation, but not immortalization, of 
mouse and human fibroblasts as shown by colony formation in soft agar (Maiorana et 
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al., 2004). Also, malignant human astrocytomas showed dramatically elevated levels of 
Pes1, strengthening its role for oncogenic transformation and tumor progression. 
Evidence for a function of the proteins during embryogenesis is given by Pes1, which 
was first identified as pescadillo in the zebrafish, where it has an essential function for 
normal embryonic development (Allende et al., 1996). Lerch-Gaggl et al. report a similar 
effect in the mouse. Pes1-depleted embryos arrest at the morula stage of development, 
fail to develop nucleoli and do not accumulate ribosomes (Lerch-Gaggl et al., 2002). 
 
 
1.4.1 Pes1 
 
A single gene located on chromosome 11 in the mouse genome encodes for murine 
Pes1, a protein of 584 amino acids and a theoretical size of 67.8 kDa, which is highly 
evolutionary conserved and shows a homology of 89% to human Pes1 (Haque et al., 
2000). The protein contains a highly conserved N-terminal pescadillo-like protein 
domain (NPLP-domain), a BRCT (BRCA1 C-terminal) domain in the middle of the 
protein and three nuclear localization sites (NLS). In addition, the C-terminus of Pes1 
contains two acidic stretches of amino acids, six bipartite NLS, plus a consensus site for 
SUMOylation (KΨXE) (Grimm et al., 2006; Haque et al., 2000; Holzel et al., 2007; 
Kinoshita et al., 2001). C- and N-terminal truncation mutants plus several transposon-
derived mutants of Pes1 displayed a dominant negative phenotype, blocking the 
processing of 36/32S rRNA into mature 28S and 5.8S rRNA and inhibited cell 
proliferation via a p53-mediated mechanism (Grimm et al., 2006; Lapik et al., 2004). 
Further, the BRCT domain of Pes1 has been elucidated to be crucial for its nucleolar 
localization and its function in rRNA processing. BRCT domains facilitate protein-protein 
interactions and are often found in factors, involved in DNA repair pathways (Holzel et 
al., 2007). 
 
 
1.4.2 Bop1  
 
Bop1 (block of proliferation) is an evolutionary conserved gene that encodes a protein 
of 732 amino acids with a molecular weight of 83 kDa in the mouse. Bop1 contains 
seven WD40 repeats, which are often involved in the formation of multiprotein 
complexes as well as two PEST sequences, one at the N-terminus and one in the 
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middle of the protein. PEST sequences are often associated with short-lived regulatory 
proteins, indicating a regulatory function for Bop1 (Strezoska et al., 2000; Strezoska et 
al., 2002). Deletion mutagenesis revealed two dominant negative mutants with an N- or 
C-terminal deletion, whose phenotype involved a reversible block of proliferation by a 
G1-arrest and an inhibition of pre-rRNA processing. In mouse cells, the processing of 
the 36S and 32S rRNA was inhibited, leading to impaired maturation of the 28S and 
5.8S rRNA (Pestov et al., 2001; Strezoska et al., 2002). 
 
 
1.4.3 WDR12 
 
Wdr12 corresponds to a single-copy gene in the mouse genome on chromosome 1, 
encoding a protein of 423 amino acids with a theoretical molecular weight of 47.3 kDa. 
The WDR12 (WD repeat) protein contains seven WD40 units and a nuclear localization 
signal located between the WD domains three and four. At its N-terminus it contains a 
Notchless-like domain (Nle). It is supposed that the 7 WD40 repeats form a "β-propeller" 
structure, likewise it has been extensively analyzed in the β-subunits of heterotrimeric 
G-proteins. Like most WD repeat proteins, WDR12 shows no enzymatic activity, but the 
propeller structure of the WD40 repeats could play a role for protein-protein interactions. 
Generally, WD repeat proteins are viewed as regulatory components within higher order 
complexes, which matches the participation of human WDR12 into the PeBoW-complex 
(Holzel et al., 2005; Nal et al., 2002). 
Deletion of the Nle domain of WDR12 has been shown to induce a dominant negative 
phenotype. Expression of the mutant in human cells impairs the maturation of 28S 
rRNA and induces a reversible arrest in G1-phase (Holzel et al., 2005). 
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1.5 Aim of the project 
 
Cell proliferation is a process where cell growth and cell division have to be tightly 
coordinated. The nucleolus, as the site of ribosome synthesis, plays an important 
function in cell growth. Nucleolar disruptions directly signal to the cell cycle machinery 
and inhibit cell cycle progression. One factor involved in proper nucleolar function is the 
PeBoW-complex and its single components Pes1, Bop1 and WDR12. The PeBoW-
complex has been shown to play a crucial role in ribosome biogenesis as well as cell 
cycle progression in several cancer cell lines. Knockdowns of its components impair 
ribosome biogenesis and induce a p53-dependent checkpoint activation, finally leading 
to a reversible block of proliferation. 
Proliferation of embryonic stem (ES) cells is, in comparison to mature cells, very rapid 
with a quite distinct cell cycle distribution. Their G1-phase is very short and lacks the 
regulatory mechanisms usually active during G1-phase in other cell types (G1/S-phase 
checkpoint). ES cells can reenter the S-phase almost directly after mitosis, which is at 
least one important factor for their rapid proliferation. First evidence for the fact that a 
proper nucleolar function might be related to proliferation of ES cells comes from 
studies on Nucleostemin, another nucleolar protein, the knockdown of which leads to 
impaired proliferation rates of stem cells (Tsai and McKay, 2002).  
The goal of this work was to investigate the expression and potential complex formation 
of the proteins Pes1, Bop1 and WDR12 in mouse ES cells and to assess whether their 
function in ribosome biogenesis is related to proliferation of ES cells. Based on the 
different cell cycle kinetics of ES cells, which are missing some of the usual control-
points, one main question was to test if inhibition of ribosome biogenesis would be able 
to activate a p53-dependent checkpoint response in ES cells, as it has been shown in 
mature cell lines. A knockdown of Pes1, Bop1 and WDR12 via small interfering RNAs 
served as the major technical feature to investigate the function of those three proteins 
in ES cells. Furthermore, a possible checkpoint response was investigated by 
addressing the protein levels of the tumor suppressor p53 and the phosphorylation state 
of its indirect target Rb (retinoblastoma gene product). As cell system, the germline 
competent mouse ES cell line CGR8 was used, which can be cultured without the use 
of feeder cells in the presence of recombinant LIF. 
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2 MATERIAL 
 
 
2.1 Cell lines 
 
CGR8  mouse ES cell line obtained from J. Heschelers Lab, Cologne  
 Originally generated from Austin G. Smith, European Collection of Cell 
Cultures (ECACC) Cat. No. 95011018 
 
NIH3T3  mouse fibroblast cell line 
 
 
2.2 Media and supplements for cell culture 
 
DMEM (4500mg/ml glucose; contains    Invitrogen 
L-glutamine and pyruvate) 
DMEM (phosphate-free)     Invitrogen 
GMEM       Sigma 
IMDM        Invitrogen 
Optimem1       Invitrogen 
Cryoconservation medium for CGR8 cells:  
10% DMSO (Roth), 90%FBS (PAA Laboratories) 
 
100 x L-glutamine (200mM)    Invitrogen 
100 x MEM (non essential amino acids)   Invitrogen 
100x Penicilline/Streptomycine    Invitrogen 
FBS        PAA Laboratories 
FBS dialysed (phosphate free)     Invitrogen  
Gelatine from porcine skin, type A    Sigma 
LIF-ESGRO       Chemicon 
ß-mercaptoethanol      Sigma 
Trypsin/EDTA      Invitrogen 
 
Lipofectamine 2000      Invitrogen 
Oligofectamine      Invitrogen 
Polyethylenimine      Sigma 
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2.3 siRNA-oligonucleotides 
 
 sense (5’-3’) antisene (5’-3’) 
murine Pes1-1  
(3’ UTR) 
CAACGCAGUUCUUAAUCCAtt UGGAUUAAGAACUGCGUUGtt 
murine Pes1-2  
(3’ UTR) 
GCAGUAUGCUUGUCCAAUUtt AAUUGGACAAGCAUACUGCtt 
murine Pes1-3 
(ORF 1645) 
CUAAGCGCUUGGCCAUCAUtt AUGAUGGCCAAGCGCUUAGtt 
murine Bop1-1 
(ORF 768) 
GAAGGUGUCUCGAAUGGUAtt UACCAUUCGAGACACCUUCtt 
murine Bop1-2 
(ORF 1350) 
GAAGACUGUACAUGUUGGAtt UCCAACAUGUACAGUCUUCtt 
murine WDR12-1 
(3’ UTR) 
UGUCCUUCGUGCUUAUAAAtt UUUAUAAGCACGAAGGACAtt 
murine WDR12-2 
(3’ UTR) 
GCAUACAACUAACCUGUAAtt UUACAGGUUAGUUGUAUGCtt 
murine WDR12-3 
(5’ UTR) 
GAUUACGAAUCUAGAUAGAtt UCUAUCUAGAUUCGUAAUCtt 
murine WDR12-4 
(3’ UTR) 
AUCAUAGCACACACUUAUAtt UAUAAGUGUGUGCUAUGAUtt 
control  
(Luciferase)  
UUCUCCGAACGUGUCACGUtt ACGUGACACGUUCGGAGAAtt 
 
 
2.4 Antibodies 
 
2.4.1 Primary antibodies 
 
 description source WB IF 
α-Pes1 Ab-1; guinea pig polyclonal Charles River Lab. 1:15000 1:500 
 Ab-3; guinea pig polyclonal Charles River Lab. 1:15000 1:500 
α-Bop1 Ab-1; guinea pig polyclonal Charles River Lab. 1:15000 1:500 
 Ab-2; guinea pig polyclonal Charles River Lab. 1:15000 1:500 
 rat monoclonal, clone 1B5 E. Kremmer, GSF 1:10 1:10 
 rat monoclonal, clone 5F4 E. Kremmer, GSF 1:10 1:10 
 rat monoclonal, clone 8G10 E. Kremmer, GSF 1:10 1:10 
 rat monoclonal, clone 1A11 E. Kremmer, GSF 1:10 1:10 
α-WDR12 Ab-3; guinea pig polyclonal Charles River Lab. 1:15000 1:500 
 Ab-4; guinea pig polyclonal Charles River Lab. 1:15000 1:500 
 rat monoclonal, clone 6A2 E. Kremmer, GSF 1:10 1:10 
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α-WDR12 rat monoclonal, clone 6B8 E. Kremmer, GSF 1:10 1:10 
 rat monoclonal, clone 8D2 E. Kremmer, GSF 1:10 1:10 
α-ß-actin mouse monoclonal, clone AC-15 Sigma 1:20000 - 
α-p21 rabbit polyclonal  (C-19) Santa Cruz 1:1000 - 
α-p53 rabbit polyclonal (FL-393) Santa Cruz 1:500 - 
α-p53 mouse monoclonal (PAb 122) Dianova - 1:100 
α-PARP rabbit polyclonal (SA-253) Biomol 1:1000 - 
α-Rb mouse monoclonal, clone G3-245 BD Pharmingen 1:500 - 
α-α-tubulin mouse monoclonal, clone DM1A Sigma 1:30000 - 
 
 
2.4.2 Secondary antibodies 
 
α-guinea-pig (HRP), donkey  Dianova Western blot 1:2500, 1:5000 
α-mouse (HRP), goat  Promega Western blot 1:2500, 1:5000 
α-rabbit (HRP), goat   Promega Western blot 1:2500, 1:5000 
α-rat (HRP), goat    Dianova  Western blot 1:2500, 1:5000 
α-guinea-pig (Cy3), goat  Dianova  Immunofluorescence 1:300 
α-mouse (Cy3), goat  Dianova Immunofluorescence 1:300 
α-rat (Cy3), goat   Dianova Immunofluorescence 1:300 
 
 
2.5 Primer  
 
 forward (5’-3’) reverse (5’-3’) 
Aldolase GGTCACAGCACTTCGTCGCACAG TCCTTGACAAGCGAGGCTGTTGGC 
Flk1 AGACATTGACATGCACAGTCTACGC GCTTGGATGACCAGCGTACTTACAG 
KLF4 TCCTTTCCTGCCAGACCAGATGC TGCCCTGTGTGTTTGCGGTAGTG 
Nanog GTTGAAGACTAGCAATGGTCTGATT GTTGCGTAAGTCTCATATTTCACCT 
Oct4 TATTGAGTATTCCCAACGAGAAGAG GAACAAAATGATGAGTGACAGACAG 
Sox2 AAGGGGAGAGATTTTCAAAGAGATA TCATAAAAGTTTTCTAGTCGGCATC 
T-bra GCTAGATACTAACAACTCCATTTTC GGTGCTATATATTGCCTTTATTATG 
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2.6 Markers (protein and DNA) 
 
1kb DNA ladder      Invitrogen 
Full range rainbow molecular weight marker Amersham Biosciences 
Pre-stained SDS molecular weight marker  Sigma  
 
 
2.7 Kits 
 
Alkaline Phosphatase Detection Kit Chemicon 
EndoFree Plasmid Maxi Kit Qiagen 
FITC BrdU Flow Kit BD Biosciences 
LightCyclerR FastStart DNA Master SYBR Green I  Roche 
QIAprep Spin Miniprep Kit Qiagen 
QIAquick PCR Purification Kit Qiagen 
RNeasy RNA Isolation Kit (Mini/Midi) Qiagen 
 
 
2.8 Disposables 
 
Bacteriological plates  Greiner 
Cell culture freezing vials Nunc 
Cell culture plastic pipettes (5-, 10-, 25ml) Costar; Falcon 
Cell culture plastic pipettes (50ml) Falcon 
Cell culture plates (6-, 10cm ) Nunc 
Cell culture plates (6-, 24-, 48-, 96-well) Falcon 
Cell scraper Sarstedt 
Centrifuge tubes (polypropylene ; 15-, 50ml) Falcon 
Combitips (1ml) Eppendorf 
Cover slips Menzel-glasses 
Eppendorf tubes (1,5-, 2ml) Eppendorf 
FACS (1,4ml U-tube) Micronic 
Filter (PES, 0,2µm) Nalgene 
Filter (for syringe; 0,2µm) Sartorius 
HyperfilmTM MP (autoradiography film) GE Healthcare 
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HyperfilmTM ECL (chemiluminescence film) GE Healthcare 
LightCycler capillaries Roche 
Nitrocellulose membrane (Hybond ECL)  Amersham Biosciences 
Pipette tips  TipOne, Molecular Bio Products 
Qiashredder columns Qiagen 
Saran wrap Toppits 
Spectrophotometer plastic cuvettes (UVette) Eppendorf 
µ-slideVI-ibidi Ibidi 
Whatman - blotting paper Schleicher and Schuell 
8-chamber slides Nunc 
 
 
2.9 Chemicals, Reagents and Enzymes  
 
Acrylamide/Bisacrylamide (Rotiphorese Gel 30) Roth 
Agarose Invitrogen 
Ammonium peroxide sulfate (APS) Roth 
Annexin V-FITC BD Biosciences 
Bradford Bio-Rad  
Bromphenol blue Sigma 
BSA  Roth 
DAPI  Sigma 
DEPC  Sigma 
DMSO Roth 
dNTPs Promega 
ECL-Western blotting detection reagents GE-Healthcare 
EDTA Merck 
Ethanol Merck 
Ethidiumbromide Sigma 
Formamide Sigma 
Formaldehyde solution 37% Merck 
Gelatine Sigma 
GIEMSA Merck 
Glycerol Roth 
Glycine Merck 
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Isopropanol Merck 
LIF-ESGRO Chemicon 
Lipofectamine 2000 Invitrogen 
ß-mercaptoethanol Sigma 
Methanol Merck 
Milkpowder Roth 
MLV Reverse transcriptase Invitrogen 
MOPS Roche 
Mounting medium Dako  
Oligonucleotides  Metabion 
Oligo(dT)15 Primer Promega 
Oligofectamine Invitrogen 
Paraformaldehyde Sigma 
Polyethylenimine Sigma 
PonceauS Sigma 
32 P-orthophosphate  GE Healthcare 
Protease inhibitor (complete EDTA free) Roche 
Propidium iodide Sigma 
Restriction enzymes New England  
RNase A Roche 
RNasin ribonuclease inhibitor Promega 
SDS Roth 
TEMED Roth 
Tris Merck 
TritonX-100 Sigma 
Trypsin/EDTA Invitrogen 
Trypan blue Gibco, Invitrogen 
Tween-20 Roth 
 
Standard chemicals, which are not mentioned in the list, were obtained from Merck, 
Sigma or Roth. 
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3 METHODS 
 
 
3.1 Cell Culture 
 
3.1.1 Culture conditions of CGR8 cells 
 
CGR8 cells were cultured in GMEM under addition of LIF in an incubator with 37°C, 5% 
CO2 and a water saturated atmosphere. Plates were coated with 0.2% gelatine prior to 
plating of cells. Splitting of cells was performed by trypsinization to detach cells from the 
plate. First, cells were washed once with 6-10ml PBS (10cm-plate), then 2ml of 
1 x Trypsin-EDTA were added and cells were incubated at 37°C for 5 minutes. The 
enzymatic reaction was stopped by addition of 8ml culture medium. Between 0.5-2ml of 
the suspension were seeded to a new gelatine-coated 10cm plate containing 10ml of 
fresh medium.  
Alternatively, the cell suspension was centrifuged at 1000rpm for 5 minutes. After 
removal of the supernatant the pellet was resuspended in fresh medium or used for 
other assays. 
 
GMEM:  445ml GMEM; 50ml FBS; 5ml 200mM L-glutamine; 250µl 0.1M ß-mercaptoethanol; 
50µl LIF (106 U/ml) 
 
PBS:   2g KCl; 2g KH2PO4; 80g NaCl; 14.3g Na2HPO4x2H2O; H2O ad 10l  
 
 
3.1.2 Culture conditions of NIH3T3 cells 
 
NIH3T3 cells were cultured in DMEM in an incubator with 37°C, 5% CO2 and a water 
saturated atmosphere. Coating of plates with gelatine was not necessary. Splitting of 
cells was performed by trypsinization as described for CGR8 cells.  
 
DMEM:  442,5ml DMEM (with glucose, L-glutamine, pyruvate); 50ml FBS; 5ml 200mM 
L-glutamine; 2.5ml 100 x penicilline/streptomycine 
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3.1.3 Differentiation of CGR8 cells 
 
For differentiation of CGR8 cells according to the “hanging drop” protocol, about 70-
80% confluent cells were trypsinized, counted and harvested by centrifugation. The 
pellet was resuspended in differentiation medium to prepare a suspension with 1 x 106 
cells/ml. This suspension was diluted to 1:40 to obtain 2.4 x 104 cells/ml. About 60-70 
drops of 20µl (500 cells) were placed into the lid of a 10cm bacteriological plate. The lid 
was then placed on a plate filled with 7ml PBS and the drops were incubated at 37°C, 
5% CO2 as “hanging drops” for 2 days. Due to the hanging state, the cells accumulate 
at the bottom of the drop and form spheroid cell aggregates - embryoid bodies (EBs). 
After 2 days, the EBs were transferred to 10cm bacteriological dishes containing 10ml 
of differentiation medium (about 200 EBs/10cm plate). Medium was changed every 
48 hours.  
 
Differentiation medium:  390ml IMDM; 100ml FBS; 5ml 200mM L-glutamine; 5ml 100x MEM; 
500µl 0.1M ß-mercaptoethanol 
 
 
3.1.4 Freezing of CGR8 cells in liquid nitrogen  
 
For long term storage CGR8 cells were frozen in liquid nitrogen. 10cm-plates with cells 
at about 80% confluency were trypsinized, harvested by centrifugation at 1000rpm and 
the pellets were dissolved in 1ml ice-cold cryoconservation medium, transferred into 
cryovials and frozen at -80°C. After 2-5 days the cells were transferred into liquid 
nitrogen. 
 
Cryoconservation medium:  10% DMSO; 90%FBS 
 
 
3.1.5 Transient transfection of CGR8 cells 
 
For transient expression of genes like eGFP, expression plasmids were transfected into 
the cells using Lipofectamine 2000. Cells at about 80% confluency were pre-incubated 
with Optimem for 30 minutes. During this time the transfection mix was prepared. 16µg 
plasmid and 32µl Lipofectamine 2000 were diluted in 1ml Optimem, respectively. After 
incubation of 5 minutes at room temperature both vials were mixed and incubated for 
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another 25 minutes at room temperature to form complexes. After removal of Optimem 
the transfection mix was added to the cells and incubated for 4-6 hours. Then it was 
replaced by culture medium. Cells were assayed the following day or later. 
 
 
3.1.6 Transfection of CGR8 cells with siRNA 
 
Transfection of cells with siRNA was usually performed twice. The day before the first 
transfection about 1.5 x 105 CGR8 cells were seeded in 6-wells. The following day the 
siRNA transfection mix was prepared: 10µl Lipofectamine 2000 were diluted in 150µl 
Optimem and incubated for 5 minutes at room temperature. Then, 150µl Optimem, 
containing 10µl of annealed siRNA (20µM), were added, mixed carefully and incubated 
for 15 minutes at room temperature. During this time cells were pre-incubated with 
1.5ml Optimem. After removal, 600µl Optimem were added per 6-well followed by 
addition of the 300µl of transfection mix. After incubation of the cells for 5-6 hours, the 
transfection mix was replaced by normal medium. The following day, the same 
procedure was repeated with the variation that incubation with the transfection mix took 
place overnight. 2.5ml of normal medium were added though after 5-6 hours of 
incubation. 
 
 
3.1.7 Transfection of NIH3T3 cells with siRNA 
 
For transfection with siRNA, NIH3T3 cells were seeded at a density of about 6 x 104 
cells per 6-well. The following day the transfection mix was prepared using 
polyethylenimine as transfection reagent. 10µl of annealed siRNA (20µM) were added 
to 250µl of Optimem containing 12µl of polyethylenimine and incubated for 15 minutes 
at room temperature. Then, the transfection mix was added directly to a 6-well 
containing 2.5ml medium. After incubation for 5-6 hours the transfection mix was 
replaced by standard cell culture medium. The following day the procedure was 
repeated.  
Alternatively, Oligofectamine was used as transfection reagent. In that case preparation 
of the transfection mix was performed as described for Lipofectamine 2000 in 
chapter 3.1.6. 
 
Methods 
30 
3.1.8 Annealing of siRNA 
 
RNA oligonucleotides were obtained from Curevac GmbH and dissolved at a 
concentration of 100µM in RNase free water and stored at -20°C. For annealing of 
siRNAs, 200µl of sense and antisense oligonucleotides (100µM) were mixed with 200µl 
of annealing buffer respectively and were then pooled. After addition of another 200µl of 
annealing buffer the final concentration of the siRNA duplex was 20µM. The samples 
were now aliquoted a 100µl and incubated for 1 minute at 90°C in a thermomixer 
(Eppendorf). Subsequently, the thermomixer was turned out and samples were slowly 
cooled down for 30-45 minutes until they reached a temperature of about 50°C. Then 
the thermomixer was switched on again to 12°C and samples were further cooled down 
to 12°C. Annealed siRNA was stored at -20°C or -80°C. 
 
Annealing buffer:  30mM HEPES-KOH, pH 7.4; 100mM KCl; 2mM MgCl2; 50mM NH4Ac 
 
 
3.1.9 Counting of cells 
 
After trypsinization of adherent cells, their concentration can be determined in a 
Neubauer-counting chamber. Therefore, 10µl of cell solution were added to the 
chamber and 4 x 16 squares were counted per sample. The respective mean value 
times 104 corresponds to the amount of cells per 1ml medium. If dead cells should be 
excluded, cells were stained prior to counting with trypan blue solution (1:1). Living cells 
with an intact membrane exclude the pigment, while it is up-taken by dead cells. Thus, 
dead cells with a porous membrane can be distinguished by their blue color.  
 
 
3.2 Protein Analyses 
 
3.2.1 Generation of antibodies 
 
3.2.1.1 Generation of polyclonal antibodies 
 
Polyclonal antibodies against murine Pes1, Bop1 and WDR12 were generated by 
immunizing guinea pigs with a mixture of the following two peptides per protein. 
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Pes1: LEKKKYERGSATNYITRNKARKKL (aa 4-27) and KRKAHDDAVRSEKKAKRT 
RPV (aa 564-584) 
Bop1: GKPHMSPASLPGKRRLEPDQELQIQ (aa 6-30) and SQEHTQVLLHQVSRRR 
SQSPFRRS HG (aa 541-566) 
WDR12: MAQLQARFYSENKKYAV (aa 1-17) and DWTDTGLLLSGGADNKLYSYSYS 
PTTS (aa 393-418) 
Peptides were synthesized by H. Rackwitz, Peptide Specialty Laboratories GmbH, 
Heidelberg. Guinea pigs of the lineage DH were immunized via 4 injections at 2-week 
intervals using CFA (1st injection) and IFA (2nd injection onwards) as adjuvant. Dosage 
was 0,24mg peptide per animal. Final bleeding was performed 8 weeks after the first 
immunization (Charles River Laboratories GmbH, Sulzfeld). Two sera were raised per 
protein, designated Pes1-Ab1 and -Ab3, Bop1-Ab1 and -Ab2 and WDR12-Ab3 and 
-Ab4. 
 
 
3.2.1.2 Generation of monoclonal antibodies 
 
Monoclonal antibodies against murine Bop1 and WDR12 were generated using the 
following peptides, coupled to ovalbumine or KLH. Peptides were synthesized by H. 
Rackwitz, Peptide Specialty Laboratories GmbH, Heidelberg. 
Bop1: GKPHMSPASLPGKRRLEPDQELQIQ (aa 6-30) and SQEHTQVLLHQVSRRR 
SQSPFRRS HG (aa 541-566) 
WDR12: MAQLQARFYSENKKYAV (aa 1-17) and DWTDTGLLLSGGADNKLYSYSYS 
PTTS (aa 393-418) 
About 50µg of the peptides coupled to KLH (or ovalbumine) were injected both 
intraperitoneally and subcutaneously into Lou/C rats using CPG2006 and incomplete 
Freund’s (TIB MOLBIOL) as adjuvant. After a 6-week interval, a final boost was given 
intraperitoneally and subcutaneously. 3 days later, the rat immune spleen cells were 
fused with the myeloma cell line P3X63-Ag8.653, according to standard procedures. 
Hybridoma supernatants were tested in a solid phase immunoassay. The plates were 
coated overnight with the peptides coupled to ovalbumine (or KLH). After blocking with 
non-fat milk, the hybridoma supernatants were incubated. Bound rat antibodies were 
detected with a cocktail of biotinylated mouse mAbs against the rat IgG heavy chains, 
thus avoiding IgM mAbs. The biotinylated mAbs were visualized with peroxidase-
labeled avidin (Vector) and o-phenylendiamine as chromogen in the peroxidase 
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reaction. The hybridomas designated Bop1-1B5, -5F4, -8G10, -1A11 (Bop1 aa 6-30) 
and WDR12-6A2 (WDR12 aa 1-17), WDR12-6B8 and -8D2 (WDR12 aa 393-418) were 
stably subcloned and used for further analysis. The immunoglobulin isotypes were 
determined using mAbs against the rat IgG heavy chains and light chains. Bop1-5F4 
antibody has the IgG subclass IgG2c, WDR12-8D2 the subclass IgG2b. All other 
antibodies have the subclass IgG2a. 
 
 
3.2.2 Western Blot Analysis 
 
3.2.2.1 Preparation of protein extracts under denaturing conditions for SDS-
PAGE 
For the analysis of total cellular proteins by Western blotting, cells were trypsinized, 
harvested by centrifugation and lysed in 1x Laemmli buffer or, alternatively, they were 
washed with PBS and lysed directly on the plate in 1x Laemmli buffer and harvested 
using a cell scraper. One confluent 6-well was lysed in about 150-200µl of buffer. 
Samples were sonicated with 10 pulses, boiled for 5 minutes at 95°C and stored at 
-20°C. 10-20µl of the lysates were loaded on a gel. 
 
1x Laemmli buffer:  50mM Tris/HCl pH 7.0; 20% glycerol; 2% SDS; 5% ß-mercaptoethanol; 
0.02% bromphenol blue 
 
 
3.2.2.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and blotting of 
proteins 
For separation of proteins by SDS-polyacrylamide gel electrophoresis, 8%, 10% or 12% 
polyacrylamide gels with 2mm thickness were used, depending on the size of the 
analyzed proteins. After loading of the lysates the gels were run at 30mA per gel in 1x 
SDS running buffer. Pre-stained markers were run simultaneously on the gel to 
estimate the molecular weight. Proteins separated by SDS-PAGE were transferred to a 
nitrocellulose membrane via wet blotting in 1x transfer buffer at 450mA and 4°C for 
1 hour. Beforehand, all components were soaked in transfer buffer and the blotting 
sandwich was built the following: sponge, Whatman paper, membrane, gel, Whatman 
paper, sponge. To control an optimal transfer of the proteins after blotting and to verify 
equal loading, the membranes were stained for 1 minute in Ponceau S solution and 
destained with H2O or TBST.  
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Stacking gel (10ml):  5,5ml H2O; 1.7ml 30% acrylamide mix (Rotiphorese Gel 30); 2.5ml 
1M Tris/HCl pH 6.8; 0.1ml 10% SDS; 0.1ml 10% APS; 10µl TEMED 
 
Resolving gel 10% (20ml):  5.4ml H2O; 6.7ml 30% acrylamide mix (Rotiphorese Gel 30); 7.5ml 
1M Tris/HCl pH 8.8; 0.2ml 10% SDS; 0.2ml 10% APS; 8µl TEMED 
 
10 x SDS running buffer:  30.2g Tris-base; 144g glycine; 50ml 20%- SDS; H2O ad 1l 
 
10 x Transfer buffer:   30.2g Tris-base; 144g glycine; 10% methanol; H2O ad 1l 
 
 
3.2.2.3 Hybridization with antibodies 
 
After blotting of the proteins (3.2.2.2), the membranes were blocked for at least 30 
minutes in TBST containing 5% non-fat milk powder. Incubation with the primary 
antibody, which was diluted in TBST/5%milk, was performed at 4°C overnight. 
Subsequently, the membranes were rinsed twice with water and washed three times for 
5 minutes in TBST, followed by incubation with the secondary antibody, diluted in 
TBST/5%milk 1:2500 to 1:5000. After 2 hours of incubation at room temperature, the 
membranes were washed three times for 5 minutes in TBST and were rinsed five times 
shortly with water. To detect protein bands, the blots were incubated for 1 minute with 
ECL-detection solution, followed by exposure to chemiluminescence films. 
 
10 x TBS:   100mM Tris; 1.4M NaCl 
1 x TBST:   1 x TBS; 0.1% Tween-20 
 
 
3.2.2.4 Stripping of membranes 
 
To detect additional proteins on a membrane, which was already used for hybridization, 
the bound antibodies were removed by shaking the membrane in stripping buffer at 
55°C for 15 minutes. Subsequently, the membrane was washed twice for 10 minutes in 
TBST at room temperature, blocked 30 minutes in blocking buffer, followed by 
hybridization with the new antibodies.  
 
Stripping buffer:  100mM ß-mercaptoethanol; 2% SDS; 62.5mM Tris/HCl pH 6.7 
Methods 
34 
3.2.3 Native Gels  
 
3.2.3.1 Preparation of protein extracts under native conditions 
 
Cells from three 10cm-plates were trypsinized, harvested by centrifugation, washed 
twice in PBS and resuspended in 200µl lysis buffer. Subsequently, cells were vortexed 
for 5 seconds, incubated on ice for 20-30 minutes with sporadic vortexing, vortexed 
again for 5 seconds and centrifuged at 16400rpm, 4°C for 10 minutes. The 
supernatants were used directly for analyses on native gels. 
 
Lysis buffer:  50mM Tris/HCl, pH 8.8; 1% NP-40; 150mM NaCl; 1 x protease 
inhibitor; 1 x phosphatase inhibitors 
 
Protease inhibitor (50x):  1 tablet complete EDTA-free protease inhibitor cocktail (Roche) in 
1ml H2O (1:50) 
Phosphatase inhibitors:  100mM sodium orthovanadate  1:100 
    1M Na-tartrate   1:500 
    100mM Na2MoO4  1:100 
 
    
3.2.3.2 Native gel electrophoresis  
 
Native gel run and blotting was performed at 4°C with all materials pre-cooled. The 
lysates (3.2.3.1) were mixed 1:1 with 2x sample buffer and loaded to one-phase 
acrylamide gels (15µl for detection of Pes1, Bop1, WDR12 and 6.5µl for detection of 
Tubulin). Gels were run at 85V until the samples had entered the gels and then at 100V. 
After separation, proteins were transferred to a nitrocellulose membrane via wet blotting 
at 450mA for 1.5 hours in blotting buffer. Hybridization with antibodies was performed 
as described in chapter 3.2.2.3. 
 
2 x sample buffer:    125mM Tris/HCl pH 6.8; 30% glycine; 0.02% bromphenol blue 
 
1 x Running/blotting buffer:  14.4g glycine; 3.02g Tris-base; H2O ad 1l 
 
Acrylamide gel (10ml):  3.88ml H2O; 2.16ml acrylamide mix (Rotiphorese Gel 30); 3.75ml 1M 
Tris/HCl pH 8.8; 0.1ml 10% APS; 8µl TEMED  
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3.2.4 Immunofluorescence 
 
Immunofluorescence with CGR8 cells was performed in ibidi µ-slides VI, which were 
pre-coated with 0.2% gelatine. NIH3T3 cells were analyzed in 8-chamber slides from 
Nunc. After the respective treatment of the cells they were washed in PBS and fixed for 
10 minutes in ice-cold methanol (alternatively for 2 minutes in 1:1 methanol/aceton). 
Subsequently, they were air-dried and rehydrated with PBS for 5 minutes. After blocking 
for at least 30 minutes in PBS/10% FBS they were incubated with the primary 
antibodies overnight at 4°C. Antibodies were diluted in PBS/1.5%FBS. The following 
day, the cells were washed three times for 3 minutes in PBS/0.04%triton and incubated 
for 1 hour at room temperature with Cy3-labeled secondary antibodies (1:300 in 
PBS/1.5%FBS). After three washes with PBS/0.04%triton cells were stained with DAPI 
(1:10000 of 5mg/ml) to counterstain the nuclei. After another wash, the chambers from 
the 8-chmaber slides were removed and cells were covered with coverslips and 
mounting medium; cells in the µ-slides could be analyzed directly under a fluorescence 
microscope. Digital images were aquired using the Openlab acquisition software 
(Improvision) and a microscope model Axiovert 200M (Zeiss) with 10x, 20x and 100x 
objectives connected to a 5-charge-coupled device camera model ORCA-479 
(Hamamatsu). 
 
 
3.3 RNA Analyses 
 
3.3.1 Isolation of total RNA 
 
Total RNA was isolated from cells using the Qiagen RNeasy® Kit according to the 
manufacturers instructions. Cells were lysed in 300-500µl RLT lysis buffer, depending 
on their density. DNA digestion with the RNase-Free DNase Set (Qiagen) was included 
to avoid contamination with genomic DNA. Finally, RNA was eluted with 30-50µl of 
RNase-free water and stored at -80°C. Concentrations of RNA were determined using 
an Eppendorf spectrophotometer. 
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3.3.2 Reverse transcription (RT) of RNA into cDNA 
 
For quantitative PCR analysis the RNA had to be transcribed into cDNA. Therefore 3µg 
(or 1µg) of RNA were diluted in autoclaved ddH2O to a final volume of 15µl. After 
addition of 3.75µl of oligo(dT)15 primer (17µM) the samples were incubated at 65°C for 5 
minutes to denature secondary structures of RNA and allow the primers to bind to the 
polyA-tails of mRNA molecules. Afterwards 11.25µl of RT-Mix were added and the 
reaction was performed for 55 minutes at 37°C, followed by inactivation of the enzyme 
for 5 minutes at 95°C. Finally, 270µl (or 90µl) of autoclaved ddH2O were added to dilute 
the samples. 
 
RT-Mix: 
4.5µl NX-buffer (0.4M KCl; 0.1M Tris/HCl pH 8.4; 20mM MgCl2; 2% Tween-20) 
3.0µl ß-mercaptoethanol (0.1M) 
1.5µl dNTPs (20mM/dNTP) 
0.75µl RNasin (40U/µl) 
1.5µl Mo-MLV reverse transcriptase (200U/µl) 
 
 
3.3.3 Quantitative real-time PCR analysis 
 
To monitor relative gene expression levels, quantitative real-time PCR (polymerase 
chain reaction) was performed with the Light-Cycler method from Roche. Amplification 
of a defined sequence of the target cDNA is monitored in this system by addition of 
SYBR Green, a fluorescent dye, which enhances its fluorescence 100 times upon 
intercalation into double-stranded DNA. Thus, the fluorescence is proportional to the 
amount of amplified DNA. It is measured after each PCR cycle (real-time). The CP- 
(crossing point) value, which is determined by the Light-Cycler program, represents the 
cycle of the PCR when the fluorescence of the samples becomes detectable compared 
to the background levels. This is depending on the amount of target cDNA. Together 
with a standard curve, which determines the efficiency of the respective PCR reaction, 
the CP-value can be used to quantify the relative amount of cDNA. For the generation 
of a standard curve, samples of a previous PCR reaction with the same 
oligonucleotides were serially diluted to 10-5, 10-7 and 10-9 and ran in the Light-Cycler. 
For quantification of future reactions, the dilution 10-5 was included in those as 
reference (calibrator). The calculation of the standard curves as well as quantification of 
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the samples was performed by the Light-Cycler program. To account for irregularities 
within cDNA transcription, the determined concentrations of all samples were 
normalized to the concentrations of the housekeeping gene Aldolase. As the cDNA, 
which served as template for the PCR reaction, was transcribed reversely from mRNA, 
the results finally reflect the relative amount of mRNA copies in the cells at the time of 
lysis normalized to the levels of Aldolase. 
Specificity of the used primers was analyzed by melting curves, determining the melting 
peak of their products. Their sequences are depicted in chapter 2.6. 
 
PCR Mix: 
5.2µl H2O 
0.8µl MgCl2  
1µl oligonucleotide-pair (5pmol/µl each) 
1µl Roche mix 
2µl cDNA (diluted 1:10 in H2O) 
 
Program for amplification: 
Activation/denaturation:  95°C; 10min 
Amplification:   95°C; 1sec 
(50 cycles)  65°C; 10sec  
    72°C; 12sec 
Melting curve:  70°C; 10sec and in 0.1°C steps to 97°C 
Cooling down:  40°C; 10sec 
 
 
3.3.4 In vivo labeling of RNA with 32P-orthophosphate 
 
For metabolic labeling of rRNA, CGR8 or NIH3T3 cells were pre-incubated in 
phosphate-free DMEM with 10% dialysed FBS for 30 minutes. Then the starvation 
medium was replaced by 1ml/6-well phosphate-free DMEM/10%dialysed FBS 
containing 15µCi 32P-orthophosphate. After 1 hour the radioactive medium was 
removed and cells were incubated in standard medium with 10% FBS for 3-4 hours, 
followed by isolation of total RNA with the Qiagen RNeasy Kit according to the 
manufacturers instructions. 1.2µg of total RNA in 15µl loading buffer were denatured at 
55°C for 15 minutes and separated on 1% agarose-formaldehyde gels (100V, 
approximately 5 hours). After electrophoresis, gels were photographed under UV light to 
visualize ethidiumbromide-stained RNA. Then the gels were dried at 80°C under 
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vacuum suction on a Whatman-paper. Dried gels were exposed to X-ray films and 
rRNA was visualized by autoradiography. 
 
1% formaldehyde gel:  4g agarose; H20 ad 300ml; boil and allow to cool to 65°C before 
adding 40ml 10x MOPS and 67ml formaldehyde (37%). 
 
10 x MOPS:    200mM MOPS; 50mM Na-acetat; 1mM EDTA; pH 7.0 with NaOH 
 
Running buffer:   1x MOPS 
 
2 x RNA loading buffer (10ml):  5ml formamide; 1.5ml formaldehyde (37%); 1ml 10x MOPS; 1ml 
bromphenol blue; 10µl ethidiumbromide; 1.5ml H20 
 
 
3.4 Cell Proliferation and Apoptosis 
 
3.4.1 Proliferation assay - cell count 
 
CGR8 cells were plated at a density of 1.5x105 cells per 6-well and transfected twice 
with the respective siRNAs at the following two days. 6 days after the first siRNA 
transfection, cell numbers were determined in a Neubauer chamber. At day 3 (or 4) 
after the first transfection, cells were passaged the following way: control siRNA-
transfected cells were split 1:10, while cells transfected with siRNAs against Pes1 or 
Bop1 were split 1:5 to 1:7.5 depending on their density. This was done to ensure 
comparable amounts of cells per 6-well after plating. The cell numbers, determined at 
day 6, were multiplied with the respective dilution factors.  
NIH3T3 cells were plated at a density of 6 x 104 per 6-well. Transfection, splitting and 
cell counts were performed in a similar manner as in CGR8 cells. Trypan blue staining 
was used to exclude dead cells. 
 
 
3.4.2 Proliferation assay - GIEMSA staining 
 
Cells were plated at a density of 1.5x105 per 6-well and incubated with or without 5FU 
(10µM or 20µM) for 48 hours. After washing with PBS, the cells were fixed with 
methanol (-20°C) for 10 minutes, dried in the airflow of the hood for 2-5 minutes and 
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stained with GIEMSA solution (1:20) for 30 minutes. Subsequently, the cells were 
washed by dipping the 6-well plate carefully, to not dislodge cells, 4-6 times into a bowl 
with ddH2O. After drying, the 6-wells were scanned with an Epson scanner.  
 
 
3.4.3 Cell cycle analysis with propidium iodide (PI) staining 
 
To analyze the DNA content of the cells by propidium iodide staining, cells from 1-3 
6-wells were washed with PBS, trypsinized and harvested by centrifugation at 1000rpm 
for 5 minutes. For fixation, cells were resuspended in 1ml of cold 80% ethanol and 
incubated for 1 hour on ice. Cells were then washed once with PBS and resuspended in 
1ml PBS, containing 50µg propidium iodide, 5µl RNase A (10units, Roche) and 2µl 
EDTA (0.5M). After 30 minutes incubation in the dark and at room temperature, for 
digestion of RNA, cells were subjected to flow cytometry in a FACScan (Becton 
Dickinson) to analyze cell cycle distribution within the population. 100000 cells were 
aquired per sample and analyzed with CellQuest software (Becton Dickinson). Cell 
debris was excluded by gating cells on a dot blot with forward and sideward scatter.  
 
 
3.4.4 Cell cycle analysis with bromodeoxyuridine (BrdU) labeling 
 
The FITC BrdU Flow Kit from BD Biosciences was used to analyze BrdU labeled cells. 
BrdU is a thymidine analogue, which is incorporated into newly synthesized DNA and 
thus labels cells in S-phase. Cells were labeled in 6-well plates with 10µM BrdU in cell 
culture medium for 30 minutes. Then, cells were washed twice with PBS, trypsinized 
and 106 cells per sample were fixed and permeabilized in 100µl of BD Cytofix/Cytoperm 
buffer for 30 minutes on ice. After addition of 1ml 1x BD Perm/Wash buffer and 
centrifugation for 5 minutes at 1200rpm the cell pellet was resuspended in 100µl of BD 
Cytperm Plus buffer and incubated for 10 minutes on ice. Following a washing step as 
described above, cells were refixed with 100µl BD Cytofix/Cytoperm buffer for 5min on 
ice. After another washing step, cells were treated for 1 hour at 37°C with 30µg DNase 
per sample to expose incorporated BrdU. After washing the cells again with 1ml 1x BD 
Perm/Wash buffer, they were stained for 20 minutes at room temperature with FITC-
conjugated anti-BrdU antibody, diluted 1:50 in 1x BD Perm/Wash buffer. 25µl of 
antibody dilution were added per sample. After another washing step, the cell pellets 
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were resuspended in 10µl 7-AAD solution to stain the total DNA content of the cells. 
Then, 0.5ml PBS was added to each sample and the stained cells were analyzed in a 
FACS Calibur flow cytometer (Becton Dickinson). 30000 cells per sample were aquired 
at a rate of no more than 400 events/second. Cell Quest software (Becton Dickinson) 
was used for analysis. For setup compensation, the following controls were included: 
1) unlabeled cells with BrdU antibody; 2) labeled cells with BrdU antibody; 3) unlabeled 
cells with 7-AAD; 4) labeled cells with BrdU antibody and 7-AAD. 
 
 
3.4.5 Annexin V staining 
 
Annexin V staining was used to determine the amount of apoptotic cells. Cells were 
harvested by trypsinization, washed twice with PBS and resuspended in 1x Annexin V-
binding buffer at a concentration of ∼1x106 cells/ml. Then 100µl of the cell suspension 
(1x105 cells) were stained by addition of 5µl Annexin V-FITC (BD Biosciences) and 2µl 
propidium iodide (50µg/ml stock) to distinguish between apoptotic and necrotic cells. 
After incubation for 15 minutes in the dark and at room temperature, 400µl 1x Annexin 
V-binding buffer were added and cells were analyzed by flow cytometry using a 
FACScan and CellQuest analysis software (Becton Dickinson). For setup 
compensation, the following controls were included: 1) unstained cells, 2) cells stained 
with Annexin V-FITC alone, 3) cells stained with PI alone. To exclude cell debris, cells 
were gated on a forward and sideward scatter dot blot. 
 
1x Annexin V-binding buffer:  10mM HEPES/NaOH pH7.4; 140mM NaCl; 2.5mM CaCl2  
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4 RESULTS 
 
 
4.1 Expression, localization and complex formation of Pes1, Bop1 and 
WDR12 in mouse embryonic stem cells  
  
4.1.1 Generation of antibodies for the detection of murine Pes1, Bop1 and 
WDR12 
 
The mammalian proteins Pes1, Bop1 and WDR12 have been shown to be involved in 
ribosome synthesis and proliferation of several cancer cell lines. In this work, the 
function of Pes1, Bop1 and WDR12 in mouse embryonic stem cells (ES cells) was 
investigated. As a model, the germline-competent mouse ES cell line CGR8 was 
chosen, which can grow without feeder layers on gelatinized plates in the presence of 
LIF. This property makes culturing conditions easier and eliminates background signals, 
derived from feeder cells. CGR8 cells were originally derived by Austin G. Smith from a 
male day 3.5 blastocyst-stage embryo of the mouse strain 129ola. The morphological 
phenotype of the cells is described as small and tightly packed cells in a singular 
cellular layer (ECACC, UK; http://www.ecacc.org.uk/). 
As former investigations in our lab about Pes1, Bop1 and WDR12 have been performed 
exclusively in human cell lines, it was necessary to produce several tools like antibodies 
and siRNAs for a proper investigation of the murine proteins. Therefore, as first step, 
polyclonal and monoclonal antibodies for all three murine proteins were generated. For 
the generation of polyclonal antibodies directed against murine Pes1, two guinea pigs 
were immunized with a mixture of an N-terminal and a C-terminal peptide of Pes1. 
Thereby, two antibodies, designated αPes1-Ab1 and αPes1-Ab3 were raised. The 
polyclonal antibodies αBop1-Ab1 and αBop1-Ab2 against murine Bop1 and αWDR12-
Ab3 and αWDR12-Ab4 against murine WDR12 were raised by immunizing guinea pigs 
with a mixture of an N- and a C-terminal peptide of Bop1 or WDR12, respectively. All 
antibodies were tested by Western blot analysis on total cell lysates of the mouse ES 
cell line CGR8 and of the mouse cell line NIH3T3, which are fibroblast-like cells. Pes1, 
Bop1 and WDR12 are expressed at high levels in CGR8 cells as well as in NIH3T3 cells 
(Fig.4). All polyclonal antibodies showed a specific staining with both cell lysates, 
detecting strong bands at the expected positions (Fig.4A-C, lanes 1-4, respectively). 
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Only αWDR12-Ab3 showed additionally a strong unspecific band with a slightly higher 
molecular weight (Fig. 4B, lanes 1/2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Analysis of Pes1, Bop1 and WDR12 with newly generated antibodies in CGR8 and 
NIH3T3 cells. The indicated polyclonal and monoclonal antibodies against Bop1 (A), WDR12 (B) 
and Pes1 (C) were tested by Western blot analysis on total cell lysates. C: CGR8; N: NIH3T3.  
 
 
Monoclonal antibodies against murine Pes1, Bop1 and WDR12 were raised in rats. For 
immunization, the same N- or C-terminal peptides were used as for the generation of 
the polyclonal antibodies. Four functional monoclonal antibodies against the N-terminus 
of Bop1 were generated (αBop1-1B5, αBop1-5F4, αBop1-8G10, αBop1-1A11), (Fig.4A, 
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lanes 5-12), but none against the C-terminal part. For WDR12, one antibody was raised 
against the N-terminus (αWDR12-6A2), (Fig.4B, lanes 5/6) and two against the C-
terminal part (αWDR12-6B8 and αWDR12-8D2), (Fig.4B, lanes 7-10). No functional 
monoclonal antibody was raised against Pes1. All monoclonal antibodies showed a very 
high specificity. The fact that the different polyclonal and monoclonal antibodies 
identified proteins of the same size at the expected positions, further underscores the 
specificity of the new antibodies. Western blot analyses of Bop1 showed a double band 
with all tested antibodies (Fig.4A). This might be due to post-translational modifications 
of Bop1 or to alternative splice variants. Alternatively, the lower band might represent a 
degradation product.  
As the polyclonal antibodies showed very good intensities on the Western blots, they 
were used for most of the experiments described below. Unless otherwise stated, 
αPes1-Ab3 was used for detection of Pes1, αBop1-Ab1 for Bop1 and αWDR12-Ab4 for 
detection of WDR12. 
 
 
4.1.2 Nucleolar localization of Pes1, Bop1 and WDR12 in CGR8 and NIH3T3 cells  
 
Pes1, Bop1 and WDR12 are expressed at high levels in the embryonic stem cell line 
CGR8. To get information about the cellular localization of the proteins in ES cells, 
indirect immunofluorescence analyses were performed. The results showed a 
predominantly nucleolar localization of all three proteins in CGR8 cells as well as a 
weak staining of the nucleoplasm (Fig.5A). The staining of WDR12 showed the 
strongest signal outside the nucleoli with additional staining in the cytoplasm. Whether 
this is due to unspecific binding of the antibody or whether WDR12 is localized 
additionally in the cytoplasm remains to be elucidated.  
In mouse NIH3T3 cells the localization of Pes1, Bop1 and WDR12 was also mainly 
nucleolar with a weak nucleoplasmic staining (Fig.5B).  
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Figure 5: Nucleolar localization of murine Pes1, Bop1 and WDR12. CGR8 (A) and NIH3T3 cells 
(B) were fixed with methanol and stained with the polyclonal antibodies αPes1-Ab3, αBop1-Ab1 and 
αWDR12-Ab4. Antigen-antibody complexes were then detected with Cy3-conjugated anti-guinea pig 
antibodies and visualized by fluorescence microscopy. Nuclei were counterstained with DAPI. 
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4.1.3 Stable complex formation of murine Pes1, Bop1 and WDR12  
 
Recent work in our laboratory has shown that Pes1, Bop1 and WDR12 form a stable 
complex in human U2OS and H1299 cells, termed PeBoW-complex (Holzel et al., 2005, 
Rohrmoser et al., 2007). To examine whether Pes1, Bop1 and WDR12 also assemble 
to a complex in mouse cells and especially in embryonic stem cells, native gel 
electrophoresis was performed with protein extracts of CGR8 and NIH3T3 cells. Cells 
were lysed using stringent, non-denaturing conditions, followed by the separation of 
stable core complexes on a polyacrylamide gel. Separation of protein complexes is 
dependent on their size, shape and charge. Subsequent immunoblot analysis of Pes1, 
Bop1 and WDR12 showed a single band with all 3 antibodies at the same position in 
the native gel, representing the PeBoW-complex (Fig.6, lanes 2-4 and 6-8). However, it 
cannot be excluded that the complex contains additional proteins. Immunoblot analysis 
of WDR12 showed in addition a faster migrating band, indicating probably free, non-
incorporated protein. This band was detected in CGR8 and NIH3T3 cells (Fig.6, lane 4 
and 8) and may indicate an additional function of WDR12 besides its integration into the 
PeBoW-complex.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Murine Pes1, Bop1 and WDR12 form a complex. Total cell lysates of CGR8 and NIH3T3 
cells were separated by native gel electrophoresis. Pes1 (polyclonal Ab3), Bop1 (polyclonal Ab1), 
WDR12 (polyclonal Ab4) and α-tubulin were visualized by immunoblotting. Free proteins and 
complexes, containing the respective factors, are indicated. 
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4.1.4 Knockdown of murine Pes1, Bop1 and WDR12 by siRNA technology 
 
The method of small interfering RNA (siRNA) knockdowns was chosen to investigate 
the function of Pes1, Bop1 and WDR12 in embryonic stem cells. Different siRNA 
sequences for the three genes have been designed and were evaluated in CGR8 cells. 
The siRNAs were directed either against the open reading frames (ORF) or the 
untranslated regions (UTR) of the respective mRNAs. As control served a siRNA 
sequence directed against the Luciferase gene. The protocol for the knockdown and 
subsequent analysis of the cells was optimized in a way that cells were seeded at low 
density, followed by transfection of siRNA in duplicate at day 0 and day 1. Analysis of 
the cells was then performed between day 2 and day 7, depending on the assays 
(Fig.7A). Evaluation of several siRNA sequences revealed two functional siRNAs 
against Pes1 and Bop1, respectively (Fig.7B/C). Unfortunately, none out of four tested 
sequences showed a significant knockdown of WDR12 (Fig.7D). Therefore, functional 
analyses of the proteins in further experiments were limited to Pes1 and Bop1. As the 
second functional siRNA against Pes1 (siRNA 3) was evaluated at a later time point, it 
could not be included in all experiments. As siRNAs often induce off-target effects, it 
was generally tried to use two different siRNAs per target gene. In case of similar 
phenotypes, this strongly reduces the possibility that the detected effects might be 
unspecific. The knockdown efficiencies were varying between different siRNA species, 
with the siRNAs No.1 against Pes1 and Bop1 giving a better knockdown than the 
siRNAs No.2 or No.3 (Fig.7B/C, lanes 3/4, respectively). This tendency was 
reproducible, but nevertheless there were variations between different experiments. 
Transfection of CGR8 cells with an eGFP expression plasmid showed that about 70% 
of the cells can be transfected with Lipofectamine 2000 (Fig.7E). Varying intensities of 
eGFP expression within different cells showed that transfection efficiency differs 
between single cells. In addition eGFP expression may be also depending on the 
overall condition of the respective cells. 
Knockdowns of the proteins also supplied further proof for the specificity of the 
antibodies against Pes1 and Bop1. The fact that both bands of Bop1, detected by 
Western blot analysis, were diminished after siRNA transfection suggests that both 
bands are specific for Bop1. 
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Figure 7: Validation of functional siRNAs for Pes1 and Bop1 but not WDR12. (A) Time schedule 
of the transfection protocol for siRNA knockdowns. (B, C, D) CGR8 cells were transfected twice with 
the indicated siRNAs using Lipofectamine 2000 as transfection reagent. Two days after the last 
transfection (day 3), cells were monitored for protein levels of Pes1 (polyclonal Ab3), Bop1 
(polyclonal Ab1) and WDR12 (polyclonal Ab4) by Western blot analysis. Mock treated cells were 
incubated with Lipofectamine 2000. Control siRNA was directed against Luciferase. α-tubulin served 
as loading control. (E) eGFP expression visualized by fluorescence microscopy after transfection of 
CGR8 cells with an eGFP expression plasmid.  
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4.1.5 Interdependency of murine Pes1 and Bop1 protein levels  
 
Stability of human Pes1, Bop1 and WDR12 proteins has been shown to be strongly 
dependent on incorporation into the PeBoW-complex (Rohrmoser et al., 2007). In line 
with these results, siRNA knockdown experiments showed a strong interdependency of 
the murine proteins in CGR8 and NIH3T3 cells. Both cell lines were transfected twice 
with siRNAs against Pes1, Bop1 and WDR12 (according to Fig.7A). Western blot 
analyses at day 3 showed that depletion of Bop1 also decreases protein levels of Pes1 
and vice versa (Fig.8, lanes 2-4 and 8-10). The effect of Pes1 depletion on Bop1 protein 
levels was stronger though. Interestingly, no clear effect of Pes1 or Bop1 knockdown on 
the WDR12 protein levels was detectable. This result might be related to the strong 
intensity of the faster migrating band on the native gels, representing most likely free 
monomers of WDR12. This further substantiates the hypothesis of an additional 
function of free WDR12 in mouse cells, independent of its function related to the 
PeBoW-complex. siRNAs against WDR12, which were shown before not to exert a 
knockdown of WDR12, served as additional controls and did not show significant 
effects.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Interdependency of murine Pes1 and Bop1 protein levels. CGR8 (A) and NIH3T3 cells 
(B) were transfected twice with the indicated siRNAs. At day 3, protein levels of Pes1, Bop1 and 
WDR12 were monitored by Western blot analysis. Control siRNA was directed against Luciferase. 
α-tubulin served as loading control.  
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4.2 A role for Pes1 and Bop1 in rRNA processing and proliferation of 
mouse ES cells  
 
4.2.1 Impaired maturation of the 28S rRNA and accumulation of the 36S pre-
rRNA upon knockdown of Pes1 and Bop1  
 
Based on the reported function of the PeBoW-complex for ribosome biogenesis, we 
aimed to investigate whether a knockdown of Pes1 and Bop1 would affect rRNA 
processing in ES cells. Therefore, maturation of nascent rRNA was analyzed by 
metabolic labeling of RNA with 32P-orthophosphate. To compare the effects to non-ES 
cells, the experiment was performed in parallel in mouse NIH3T3 cells. Both cell lines 
were transfected twice with the respective siRNAs against Pes1, Bop1 and with the 
control siRNA against Luciferase. Two siRNAs directed against WDR12, which were 
shown before to have no significant effect on the protein level of WDR12, were included 
as additional controls in CGR8 cells. Two days after the last transfection, the cells were 
starved for 30 minutes in phosphate free medium and then RNA was pulse-labeled for 
1 hour by addition of 32P-orthophosphate-containing medium. After a chase time of 
3-4 hours with normal medium, total RNA was isolated and separated on an agarose-
formaldehyde gel. Exposure of the dried gel to an X-ray film led to visualization of 
labeled, i.e., de novo synthesized and processed ribosomal RNA. Ethidiumbromide 
staining of total RNA served as loading control. In both cell lines, Pes1- and Bop1-
depleted cells showed a reduction of the 28S rRNA levels in comparison to cells treated 
with control siRNA. In contrast, the amount of the 36S rRNA was increased in the Pes1- 
or Bop1-depleted cells. The amount of 32S rRNA showed no significant changes, nor 
did the 45/47S precursor. Also, the amount of 18S rRNA was not changed (Fig.9A). A 
similar effect was observed at day 2 and day 4, shown at the example of Bop1-depleted 
CGR8 cells (Fig.9B). The observed effects were comparable between CGR8 and 
NIH3T3 cells with a slightly stronger decrease of the 28S rRNA in NIH3T3 cells. The 
intensities of the observed effects were comparable to the knockdown efficiencies, 
achieved with the respective siRNAs (compare to Fig.8). Namely, the effect observed 
on 28S rRNA was stronger after depletion of Bop1 with siRNA-1 than with siRNA-2. In 
cells transfected with siRNAs against WDR12, only a marginal effect was observed.  
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Figure 9: Knockdown of Pes1 or Bop1 inhibits the processing of the 36S and 32S precursors 
into the 28S rRNA. (A) CGR8 and NIH3T3 cells, transfected twice with the indicated siRNAs, were 
starved for 30 minutes in phosphate-free medium at day 3 (see Fig. 4A). Subsequently, they were 
pulse-labeled for 1 hour with 32P-orthophosphate. After a chase time of 3-4 hours in regular medium, 
RNA was isolated, resolved on a 1% formaldehyde gel and visualized by autoradiography. Labeled 
rRNAs are indicated. Whole RNA staining with ethidiumbromide served as loading control. (B, C) 
CGR8 cells were treated as described in A, except that the pulse-labeling was performed at day 2 
and day 4. (D) Model of rRNA processing in mammalian cells. Numbers indicate the cleavage sites 
within the rRNA. Bars indicate the stages, where knockdowns of Pes1 and Bop1 block processing. 
ETS: external transcribed spacers; ITS: internal transcribed spacers. 
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The results imply an essential function for Pes1 and Bop1 during rRNA processing of 
ES cells. As maturation of the 18S rRNA was not affected, Pes1 and Bop1 seem to be 
involved in the production of the large 60S ribosomal subunit only, whose maturation is 
dependent on sufficiently processed 28S rRNA. The results further suggest a function 
for Bop1 and Pes1 during processing of the 36S- into the 32S precursor rRNA and for 
processing of the 32S precursor rRNA into the mature 28S rRNA. A proposed model for 
the role of Pes1 and Bop1 in rRNA maturation is shown in figure 9C.  
 
 
4.2.2 Retarded proliferation of CGR8 and NIH3T3 cells after Pes1 and Bop1 
knockdowns 
 
Proliferation of ES cells is very rapid and their cell cycle has distinct features from that 
of adult cells lacking some of the usual control mechanisms. We were interested to 
assess the function of the PeBoW-complex for ES cell proliferation under these different 
conditions. CGR8 and NIH3T3 cells were seeded at low density and transfected twice 
with the respective siRNAs against Pes1, Bop1 and WDR12 or with a control siRNA 
directed against Luciferase. To monitor the proliferation rate, cell numbers were 
determined in triplicate at day 6 (compare to Fig.7A). Knockdown efficiencies were 
verified by Western blot analysis two days after the second siRNA transfection 
(Fig.10A-D right panel). Proliferation rates of both, ES cells and NIH3T3 cells, were 
strongly impaired after knockdowns of Pes1 and Bop1 (Fig.10A-D, left panel). Cell 
numbers were reduced to 35% compared to the control in CGR8 cells and to 25% in 
NIH3T3 cells. Again, the knockdown efficiencies correlated directly with the negative 
effect on proliferation. Knockdowns of WDR12 were again not successful, although a 
weak reduction of protein could be observed by siRNAs-1 and -2. Additionally, no 
significant effect was observed on proliferation, except for cells treated with siRNA-2. 
Those were reduced to 75% compared to cells, treated with control siRNA (Fig.10C). 
This effect might be related to the weak decrease in WDR12 protein levels. Control 
siRNA led to a weak reduction of proliferation compared to mock-treated cells, which 
might be related to siRNA uptake in general. 
In summary, Pes1 and Bop1 seem to be essential factors for the high proliferation rate 
of ES cells. Moreover, the correlation between the degree of impairment on rRNA 
processing and proliferation, depending on the respective siRNAs, might be indicative 
of a link between the two processes.  
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Figure 10: Knockdowns of Pes1 and Bop1 negatively affect proliferation. (A, B, C) CGR8 cells 
were transfected twice with the indicated siRNAs. At day 6 cell numbers were determined in a 
Neubauer chamber. Relative cell numbers are shown in a histogram compared to control siRNA-
transfected cells, which were set to 100%. Mock cells were treated with Lipofectamine 2000. Error 
bars indicate the SD. Protein levels of Pes1, Bop1 and WDR12 were analyzed by Western blot 
analysis. Lysates were made at day 3. (D) NIH3T3 cells were treated as described in A and 
presented as relative cell numbers compared to control siRNA-treated cells, which were set to 100%. 
Lysates for the corresponding Western blot analyses were made at day 3. 
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4.3 Expression of Pes1, Bop1 and WDR12 during differentiation and a 
possible role for self-renewal of ES cells 
 
Much evidence points towards the notion that the high proliferation rate of ES cells is a 
property linked to their self-renewal capacity. As Pes1 and Bop1 seem to be essential 
factors for the proliferation of ES cells, the question arose whether Pes1 and Bop1 
might have a function in the maintenance of pluripotency. Moreover, we were interested 
in the expression of Pes1, Bop1 and WDR2 during differentiation of ES cells, as cell 
cycle kinetics change and proliferation slows down during this process.  
 
 
4.3.1 Downregulation of Pes1, Bop1 and WDR12 during differentiation   
 
To investigate the expression of Pes1, Bop1 and WDR12 during differentiation, CGR8 
cells were allowed to differentiate using the “hanging drop” protocol (Fig.11). For this 
procedure, undifferentiated CGR8 cells were trypsinized and transferred into medium 
without LIF. From this cell suspension, drops containing 500 cells were placed into the 
lid of bacteriological plates and kept upside down in an incubator for two days. During 
this time the cells start to form spheroid cell aggregates, also called embryoid bodies 
(EBs). At day 2, the EBs were harvested and further cultivated for 2-12 days in 
suspension. Alternatively, EBs can be transferred at day 4 or 6 to gelatinized 24-well 
plates for further cultivation. The differentiation process within EBs strongly reflects the 
differentiation processes taking place in a proper embryo. Cells differentiate via 
derivatives of the 3 germlayers of ectoderm, endoderm and mesoderm into lineage 
specific progenitors and finally into differentiated cells. The advantage of the “hanging 
drop” method is that the individual EBs develop similar in size and differentiate in a 
synchronous manner (Wobus et al., 1991). 
To assess differentiation of CGR8 cells, EBs were harvested every second day, 
followed by RNA and protein isolation. One method to monitor the differentiation 
process is to investigate the expression of certain marker genes by real-time PCR. 
Therefore, RNA was transcribed into cDNA and analyzed for the expression of specific 
differentiation- and pluripotency-markers. The markers Oct4, Nanog, Sox2 and KLF4, 
which are indicative of pluripotency, were downregulated during the differentiation 
process, while Flk1, an early mesodermal marker, was upregulated, starting to express 
at day 4 (Fig.12A). T-bra, a gastrulation and early mesodermal marker, was induced at 
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day 4. Thus, the observed regulation of these markers confirmed differentiation of the 
cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Differentiation of mouse ES cells by the “hanging drop” method. Undifferentiated 
CGR8 cells with 70-80% confluency were trypsinized, washed with PBS and resuspended in 
differentiation medium at a final concentration of 2.4 x 104 cells/ml. About 70 drops (20µl each) 
containing 500 cells were placed into the lid of a 10cm plate and incubated upside down for 2 days at 
37°C, which leads to formation of embryoid bodies (EBs). At day 2, the EBs were transferred into 
bacteriological plates containing 10ml of differentiation medium and expanded there for at least two 
days. Then they were either plated into gelatine-coated 24-well plates or further expanded in the 
bacteriological plates for several more days. Medium was exchanged every second day. The cells 
within the EBs differentiated into ectodermal, endodermal and mesodermal cells. 
 
 
Expression of Pes1, Bop1 and WDR12 was analyzed by Western blot analysis. The 
levels of all three proteins were downregulated at day 6 of differentiation (Fig.9B). Since 
ES cells start to adapt to a regulatory cell cycle during differentiation (White et al., 
2005), expression and phosphorylation of Rb was determined. Rb switched from its 
mainly hyper-phosphorylated, inactive form, present in undifferentiated cells, to the 
hypo-phosphorylated, active form at day 6 of differentiation (Fig.9B), indicating a 
change towards a regulated Rb-E2F pathway at this stage of differentiation. 
Interestingly, at day 2 of differentiation a significant induction of the overall amount of 
Rb could be detected, mainly of the inactive form. A similar effect on Rb was detected 
after depletion of Pes1 and Bop1 in CGR8 cells (see Fig. 16A). This might suggest that 
depletion of Pes1 and Bop1 cause certain changes in ES cells, which could reflect a 
very early differentiation process. 
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Figure 12: Pes1, Bop1 and WDR12 are downregulated during differentiation and Rb is hypo-
phosphorylated. (A) Relative mRNA levels of the indicated genes during differentiation of CGR8 
cells, measured by Light-Cycler analysis. Values were normalized to Aldolase. (B) Western blots 
monitoring expression of Pes1, Bop1, WDR12 and Rb during CGR8 cell differentiation. pRb: hypo-
phosphorylated Rb; ppRb: hyper-phosphorylated Rb. 
 
 
4.3.2 Expression of pluripotency markers in CGR8 cells after depletion of Bop1 
or Pes1  
 
The proposed link between proliferation and self-renewal of ES cells together with the 
above described results prompted us to assess whether the PeBoW-complex might be 
involved in the maintenance of pluripotency and/or whether depletion of Bop1 or Pes1 
might induce an early differentiation process in ES cells.  
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Figure 13: Expression of pluripotency markers after depletion of Pes1 or Bop1. (A) Alkaline 
phosphatase staining of CGR8 cell colonies. Cells were transfected twice with the indicated siRNA 
and plated one day after the second transfection to 6-well plates, followed by PFA fixation and AP-
staining 5 days later. (B) A higher magnification of the images shown in A. (C) Cells were treated as 
in A but cultured without addition of LIF. (D) Relative mRNA levels from the indicated genes. CGR8 
cells were transfected twice with the indicated siRNAs, RNA was isolated at day 3 and day 7, 
transcribed to cDNA and analyzed by Light-Cycler analysis. Values were normalized to Aldolase. 
Mean values of two independent experiments are shown. 
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One characteristic marker for the undifferentiated state of stem cells is high expression 
of alkaline phosphatase (AP). To examine AP expression, siRNA transfected cells were 
seeded at very low densities into 6-well plates and cultured for 5 days with or without 
addition of LIF to form colonies. Then, cells were analyzed for alkaline phosphatase 
activity by addition of a substrate, which is transformed by the enzyme into a colored 
dye. All colonies from control and Pes1- or Bop1-depleted cells that were cultured under 
addition of LIF stained positive for alkaline phosphatase activity, reflecting the 
undifferentiated state of the cells. The morphology of the colonies was small with tightly 
packed cells. Fewer colonies were present in the wells containing Pes1- or Bop1-
depleted cells (Fig.13A, B). Cells that were cultured without addition of LIF formed much 
larger and more widespread colonies. Only about 50% of the cells stained positive for 
AP, usually the ones in the centre of a colony. Moreover, AP staining was less intense 
(Fig.13C). Wells with Pes1- and Bop1-depleted cells contained less cells, but no 
significant change in the morphology of the colonies nor in the intensity of AP staining 
was observed. This indicates that the early differentiation of Pes1- and Bop1-depleted 
cells is not disturbed.  
In a next step, the mRNA levels of the pluripotency-markers Nanog, Sox2 and KLF4 
were investigated. For this test, CGR8 cells were transfected twice with Bop1 and 
control siRNAs, followed by RNA isolation at day 3 and day 7 and Light-Cycler analysis. 
None of the three examined markers showed a significant downregulation in Bop1-
depleted cells compared to cells transfected with control siRNA (Fig.13D). Although 
some variations in expression levels were observed, those were less than the 
differences between the controls at day 3 and 7 and therefore probably not significant. 
A corresponding downregulation of the same markers at day 2 of differentiation is 
shown in figure 12A. These first results argue against a change of the cells towards 
early differentiation upon depletion of Bop1.  
 
 
4.3.3 Expression and phosphorylation of Rb during differentiation of Bop1-
depleted CGR8 cells  
 
Another assumption was that depletion of Pes1 or Bop1 might make CGR8 cells more 
prone to differentiation if exposed to a differentiation stimulus. This was investigated 
indirectly by examining the expression and phosphorylation levels of Rb, which were 
shown to be regulated during differentiation (compare to Fig.9). Bop1 and control siRNA 
transfected cells were differentiated one day after the second siRNA transfection via the 
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“hanging drop” protocol. Lysates of each day of differentiation were analyzed by 
Western blot for the expression and phosphorylation of Rb. The Rb pattern showed no 
change between Bop1 siRNA-treated and control siRNA-treated cells (Fig.14). In all 
samples an increase of the overall level of Rb levels was detected at day 1 and day 2 of 
differentiation and the switch to a predominant expression of the active, hypo-
phosphorylated form took place at day 6. Indirectly, this first result points against a 
favored or faster differentiation of CGR8 cells after Bop1 depletion. However, to clearly 
argue against favored differentiation, bona-fide differentiation markers should be 
investigated in addition. Moreover, it has to be considered that the knockdown of Bop1 
by siRNA technology is only transient. But as differentiation is a process over several 
days, a stable and also a more profound knockdown might be important for detectable 
effects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Expression and phosphorylation of Rb is not changed during differentiation of 
Bop1 depleted CGR8 cells. Cells were transfected twice with the indicated siRNAs and 
differentiated according to the “hanging drop” protocol, one day after the second siRNA transfection. 
Total cell lysates from day 1-4, 6 and 8 of differentiation were analyzed by Western blotting. pRb: 
hypo-phosphorylated Rb; ppRb: hyper-phosphorylated Rb. 
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4.4 Cross talk between ribosome biogenesis and proliferation of ES 
cells 
 
4.4.1 Induction of the tumor suppressor p53 in CGR8 cells upon Pes1 and Bop1 
depletion 
 
There is strong evidence that nucleolar stress is related to cell proliferation. As we 
observed defects in ES cell proliferation as well as in rRNA maturation upon depletion 
of Pes1 and Bop1, we aimed to investigate a link of the two processes in ES cells. One 
important factor involved in a lot of cellular stresses is the transcription factor and tumor 
suppressor p53. In mature cells, p53 is induced upon inhibition of ribosome biogenesis 
and exerts a cell cycle arrest in G1-phase. In ES cells, the function of p53 is not clear. 
Inactivity of p53 and inability of the cells to undergo a G1-arrest was reported for 
example after DNA damage (Hong et al., 2004). To examine whether impaired 
ribosome biogenesis can activate a p53-dependent checkpoint in ES cells, the protein 
levels of p53 were analyzed by Western blot analysis after Pes1 and Bop1 knockdowns. 
The amount of p53 was highly induced in Pes1- and Bop1-depleted cells compared to 
control siRNA-treated cells (Fig.15). Again the intensity of p53 induction was in 
correlation with the knockdown efficiencies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: The tumor suppressor p53 is induced in CGR8 cells after depletion of Pes1 and 
Bop1. CGR8 cells were transfected twice with the indicated siRNAs. p53 protein levels were 
monitored by Western blot analysis at day 3. Pes1 (polyclonal Ab3) and Bop1 (polyclonal Ab1) are 
shown to monitor knockdown efficiency. α-tubulin served as loading control. 
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4.4.2 Investigation of apoptosis after Pes1 and Bop1 knockdown 
 
Apoptosis and cell cycle arrest are two main pathways, which are regulated by p53. To 
assess whether one of the two mechanisms is activated by the p53 induction after 
depletion of Pes1 and Bop1, apoptosis and cell cycle distribution of CGR8 cells were 
analyzed. Apoptosis was investigated via annexin V staining and PARP cleavage. 
 
 
4.4.2.1 Analysis of apoptosis by annexin V staining 
 
First, the amount of apoptotic cells was examined via annexin V staining. Apoptosis or 
programmed cell death is an active process, which involves a variety of morphological 
changes like loss of membrane asymmetry, cell shrinkage and DNA fragmentation. 
Early features of cells, undergoing apoptosis, are changes in the plasma membrane 
including exposure of the phospholipid phosphatidylserine (PS) to the outer leaflet of 
the membrane. In viable cells, PS is located only on the cytoplasmic surface of the 
membrane. Annexin V is a phospholipid binding protein with high affinity to PS and can 
be used therefore for the detection of apoptotic cells, which expose PS. Positive stained 
cells can be counted by FACS analysis. In addition, cells were stained with propidium 
iodide (PI), which served to distinguish viable from dead cells. Dead cells are 
permeable for PI due to disruptions in their membrane, while viable cells can exclude 
PI. Cells that are negative for annexin V and PI staining represent viable cells; double 
positive cells represent dead cells that may have died by apoptosis or necrosis. 
The positive control (cells treated with Actinomycin D) showed a more than 3-fold 
increase in annexin V positive cells as well as annexin V and PI double positive cells 
(Fig.16A,B). In contrast, Pes1- and Bop1-depleted cells showed no clear increase of 
annexin V positive or annexin V and PI double positive cells compared to cells treated 
with control siRNA. Annexin V staining was measured at day 3 and day 5 post siRNA 
transfections. A very weak increase of apoptotic cells could be detected for Bop1-
depleted cells at day 3 and for Pes1 siRNA3-treated cells (Fig.16A,B). Surprisingly, the 
controls also showed quite strong variations in the amount of dead cells. One 
explanation might be the use of different batches of cells for the experiments with Pes1 
depletion compared to the experiments after Bop1 depletion, which were performed 
independently. The increase in dead cells at day 5 might be related to passaging of 
cells at day 3/4. 
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Figure 16: Analysis of cell death after Pes1 and Bop1 depletion. CGR8 cells, transfected twice 
with the indicated siRNAs, were stained with annexin V and propidium iodide (PI) and analyzed by 
FACS. Actinomycin D treated cells (overnight with 20nM) served as positive control. (A) Dot blots of 
annexin V/PI stained cells at day 3. (B) Results from day 3 and day 5 shown as diagram with LR 
representing the percentage of annexin V positive cells and UR representing annexin V and PI 
double positive cells. LR: lower right quadrant, UR: upper right quadrant from the respective dot 
blots. 
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4.4.2.2 Analysis of PARP cleavage to examine apoptosis 
 
To verify the absence of a detectable effect on apoptosis, indicated by Annexin V 
staining, another assay was performed, investigating the cleavage of poly(ADP-ribose)-
polymerase (PARP). PARP is involved in DNA damage and repair mechanisms. During 
apoptosis PARP is cleaved by the protease caspase-3 from the native 116kDa protein 
into an 85kDA and a 24kDa fragment. 
Consistent with the negative results from the annexin V staining, no increase in the 
cleaved 85kDa form of PARP was observed compared to control siRNA-treated cells 
after Pes1 or Bop1 knockdowns (Fig.17, lanes 1-6). Actinomycin D treated cells showed 
an induction of the 85kDA form, which served as positive control (Fig.17, lanes 7-8). A 
small amount of the 85kDA form could be detected in all transfected cells. Most likely, 
this is due to a certain amount of apoptosis induced by the transfection stress. 
 
 
 
 
 
 
 
 
 
Figure 17: PARP cleavage into the 85kDa fragment is not enhanced upon depletion of Pes1 
and Bop1. CGR8 cells were transfected twice with the indicated siRNAs, harvested at day 3 
including supernatants, followed by Western blot analysis for detection of PARP. Untreated cells 
were included as negative control, Actinomycin D treated cells (20nM overnight) as positive control. 
An unspecific band served as loading control. 
 
 
4.4.3 Cell-cycle distribution of CGR8 cells after Pes1 and Bop1 depletion 
 
Next, the cell cycle profile of embryonic stem cells was investigated after depletion of 
Pes1 and Bop1. CGR8 cells were transfected twice with the respective siRNAs and 
labeled for 30 minutes with 10µM bromodeoxyuridine (BrdU) at day 3 (compare Fig.7A). 
BrdU is a thymidine analogue, which is incorporated into newly synthesized DNA. 
Incorporated BrdU was then stained with an anti-BrdU antibody and positive cells were 
counted by FACS analysis. In parallel, cells were stained with 7-AAD (7-amino 
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actinomycin D) to measure the DNA content. 7-AAD intercalates into DNA and can be 
used in place of PI. Its advantage over PI is a minimal spectral overlap with PE and 
FITC. Pes1- and Bop1-depleted cells showed a slight decrease of cells in S-phase 
compared to control siRNA-treated cells (Fig.18). In turn, there was a slight increase of 
cells in G1-phase. BrdU labeling at day 4 showed similar results (data not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Cell cycle profiles of Pes1 and Bop1 depleted cells, measured by BrdU staining. 
CGR8 cells were transfected twice with the indicated siRNAs. At day 3, proliferating cells were 
labeled for 30 minutes with 10µM BrdU, fixed, stained with an anti-BrdU antibody and PI and 
analyzed by FACS analysis. (A) Representative dot blots and histograms of BrdU- and PI-labeled 
cells with the indicated knockdowns. Cells with a DNA content between 2N and 4N are shown. (B) 
Diagram of the percentage of cells in G1/G0-, S-, and G2/M-phase. Mean values of two independent 
experiments are shown. Values were calculated using Cell Quest software. (C) Respective 
knockdown efficiencies. 
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4.4.4 Induction of the retinoblastoma tumor suppressor gene product Rb in 
CGR8 cells after depletion of Pes1 and Bop1 
 
To further elucidate a putative p53-mediated response mechanism, phosphorylation of 
the tumor suppressor Rb was investigated, which is one main factor involved in cell 
cycle arrest. After cellular stress, Rb is usually activated via the p53-p21 pathway. 
CGR8 and NIH3T3 cells were transfected twice with siRNAs against Pes1, Bop1 and 
control siRNA. Two days after the second transfection, cells were harvested and Rb 
was monitored by Western blot analysis. After depletion of Pes1 and Bop1, a strong 
increase in the overall amount of Rb was observed in both cell lines. In CGR8 cells, the 
main increase was interestingly in the hyper-phosphorylated, inactive form of Rb 
(Fig.19A). In addition, a slight increase in the hypo-phosphorylated, active form was 
visible, which is involved in the regulation of the cell cycle and a G1-checkpoint. The 
weak increase of cells in G1- and the corresponding decrease of cells in S-phase upon 
depletion of Pes1 and Bop1 (compare Fig.18) might be correlated with this slight 
increase of hypo-phosphorylated Rb. The role of the induction of hyper-phosphorylated 
Rb remains to be elucidated.  
In contrast to ES cells, an induction of hypo-phosphorylated, active Rb was observed in 
NIH3T3 cells after depletion of Pes1 and Bop1, but no increase in hyper-
phosphorylated, inactive Rb (Fig.19B). This indicates a functional checkpoint response 
in those cells, leading to an Rb-mediated arrest of cells in G1-phase. 
 
 
4.4.5 The cell cycle inhibitor p21 is undetectable in CGR8 cells after depletion of 
Pes1 or Bop1 
 
To further examine the role of the p53 induction after Pes1 and Bop1 depletion in CGR8 
cells, samples of the lysates shown in figure 16A were examined for the Cdk-inhibitor 
p21. As a direct target gene of p53, p21 can serve to measure the transcriptional 
activity of p53. On the respective Western blot p21 was hardly detectable even after 
prolonged exposure times. In Actinomycin D treated NIH3T3 cells, which served as 
positive control, a strong band could be detected at the expected position of the blot 
(Fig.19C) even though NIH3T3 cells expressed much lower levels of p53 than CGR8 
cells. These data indicate that p53 might not be fully active in CGR8 cells despite its 
strong induction. To investigate p53 transcriptional activity in more detail, mRNA levels 
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of p21 should also be examined. Additionally, other mechanisms like promoter silencing 
or proteasomal degradation of p21 might be explanations why the protein levels of p21 
are not induced. Overall, the data support the notion that the p53-p21 pathway, which 
usually leads to a G1-arrest in mature cells, might not be functional in CGR8 cells after 
depletion of Pes1 or Bop1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Regulation of Rb, p21 and p53 after Pes1 and Bop1 knockdowns. CGR8 (A) and 
NIH3T3 cells (B), transfected twice with the indicated siRNAs, were harvested at day 3 and 
expression of Rb was detected by Western blot analysis. Detection of Pes1 and Bop1 confirmed 
functional knockdowns and α-tubulin verified equal loading. (C) The samples from A were monitored 
for p21 and p53 expression. NIH3T3 cells, treated overnight with 20nM of Actinomycin D, served as 
positive control. pRb: hypo-phosphorylated Rb; ppRb: hyper-phosphorylated Rb. 
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4.5 Use of 5-fluorouracil as potent inhibitor of ribosome biogenesis to 
investigate a possible checkpoint activation in mouse ES cells 
 
Throughout the experiments it was observed that siRNA technology does not work as 
efficiently in ES cells as in other cell types. Based on the number of GFP-positive cells 
after transfection with an appropriate expression vector, we estimate that about 70% of 
the cells can be reached by transfection (Fig.7E). Moreover, since ES cells proliferate 
very rapidly, siRNA effects would be more transient than in other cells because siRNAs 
will be quickly diluted out and normally proliferating cells will rapidly overgrow 
transfected, arrested cells. To overcome these limitations, we studied the effects of a 
strong nucleolar stress on ES cells to independently assess a possible link between 
ribosome biogenesis and proliferation in ES cells. To this end, we used the 
chemotherapeutic agent 5-Fluorouracil (5FU), which is a cytotoxic drug used for the 
treatment of a variety of solid tumors. Its anti-tumor effect is, at least in part, due to the 
induction of a p53-dependent cell cycle arrest and apoptosis. At low concentrations 
(10µM-100µM) 5FU was shown to activate p53 by inhibition of rRNA processing and 
induction of ribosomal stress, while higher concentrations (100µM-500µM) lead to DNA 
damage and phosphorylation of p53 at serine 15, possibly due to ATM activation 
(Gilkes et al., 2006). 
 
 
4.5.1 Block of rRNA processing and inhibition of CGR8 cell proliferation upon 
5FU-treatment 
 
Treatment of CGR8 cells with 10µM and 20µM of 5FU for 22 hours resulted in a major 
inhibition of rRNA processing analyzed by in vivo labeling of newly synthesized rRNA 
with radioactive 32P-orthophosphate. Both concentrations of 5FU blocked the maturation 
of 18S as well as 28S rRNA completely (Fig.20). Moreover, already the maturation of 
the 36S and 32S rRNA intermediates was strongly reduced. Instead, a slight increase of 
the 45/47S precursor was detected.  
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Figure 20: 5FU treatment blocks rRNA processing. CGR8 cells were treated overnight with 10µM 
and 20µM 5FU, with DMSO (4µl/ml medium) or left untreated. After starvation for 30 minutes in 
phosphate-free medium cells were pulse-labeled for 1 hour with 32P-orthophosphate, followed by a 
chase of 3-4 hours. Equal amounts of isolated RNA were resolved on a 1% formaldehyde gel and 
visualized by autoradiography. Labeled rRNAs are indicated. As loading control, whole RNA was 
stained with ethidiumbromide.   
 
 
Cell proliferation of CGR8 and NIH3T3 cells was strongly reduced after 5FU treatment, 
as shown by GIEMSA staining of cells after fixation with methanol (Fig.21). Staining of 
control and DMSO-treated cells was much more intensive due to more cells per 6-well 
plate. Inhibition of cell proliferation was comparable between CGR8 and NIH3T3 cells. 
 
 
 
 
 
 
 
 
 
 
Figure 21: 5FU inhibits cell proliferation. CGR8 and NIH3T3 cells were seeded at equal densities 
in 6 well plates and treated for 48 hours with 10µM and 20µM 5FU, DMSO (4µl/ml medium) or left 
untreated. To estimate the amount of cells per well, cells were fixed with methanol and stained with 
GIEMSA. 
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4.5.2 Strong induction of p53 and Rb but not p21 upon treatment of CGR8 cells 
with 5FU 
 
Treatment of CGR8 cells with 5FU resulted in a strong induction of p53 protein levels. 
Levels of p21 proteins were only marginally induced, with the bands detectable only 
after an exposure time of 30 minutes or longer (Fig.22 lanes 1-4). Moreover, 5FU-
treated CGR8 cells showed an extensive induction of total Rb protein levels with the 
main increase in the hyper-phosphorylated, inactive form of Rb (ppRb). Conversely, 
only a weak induction of hypo-phosphorylated, active Rb (pRb) was observed (Fig.22, 
lanes 1-4). The overall ratio between ppRb:pRb was unchanged. The fact that the ratio 
was not changed towards active pRb is in line with the impaired induction of p21 that 
usually inhibits the activities of cyclin/Cdk complexes, which are involved in Rb 
phosphorylation. Overall, much higher amounts of total Rb seem to be present in CGR8 
cells compared to NIH3T3 cells in opposite to the p21 levels, which are undetectable in 
CGR8 control cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: Regulation of Rb, p21 and p53 after 5FU treatment of CGR8 and NIH3T3 cells. CGR8 
and NIH3T3 cells were treated with 10µM and 20µM 5FU or DMSO (4µl/ml medium) for 22 hours or 
left untreated. Total cell lysates were monitored by Western blot analysis for protein levels of p53, 
p21 and Rb. α-tubulin served as loading control. pRb: hypo-phosphorylated Rb; ppRb: hyper-
phosphorylated Rb. 
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In contrast to ES cells, p21 was highly induced in NIH3T3 cells upon 5FU treatment. In 
line with this finding, NIH3T3 cells showed an increase in active pRb but not inactive 
ppRb, compared to an equal, weak expression of pRb and ppRb in untreated and 
DMSO treated cells. Interestingly, only a very weak induction of p53 was detected 
(Fig.22, lanes 5-8). Hence, it seems that additional factors might be involved in the 
induction of p21 in NIH3T3 cells. 
 
 
4.5.3  Nuclear localization of induced p53  
 
As p53 induction in CGR8 cells after 5FU treatment did not lead to the expected robust 
induction of p21 or to strong hypo-phosphorylation of Rb, the localization of p53 was 
investigated. Published data indicated cytoplasmic localization and therefore 
transcriptionally inactive p53 after cellular stresses like DNA damage (Aladjem et al., 
1998; Hong and Stambrook, 2004). Indirect immunofluorescence analysis confirmed an 
upregulation of p53 protein levels in CGR8 cells and showed also a weak induction in 
NIH3T3 cells after treatment with 10µM and 20µM of 5FU. The overall expression of 
p53 in 5FU-treated and non-treated cells was much stronger in CGR8 cells than in 
NIH3T3 cells (Fig.23A,B). In both cell lines localization of p53 was mainly nuclear. 
Therefore, the cellular localization cannot explain the lack of p21 upregulation, 
suggesting a different deficit in inductive mechanisms. 
 
 
4.5.4 Accumulation of CGR8 cells in S-phase after incubation with 5FU 
 
Next, the cell cycle profiles of CGR8 and NIH3T3 cells after 5FU treatment were 
monitored. Cells were incubated for 22h and 46h with or without 5FU, followed by FACS 
analysis of PI stained cells. NIH3T3 cells accumulated in G1- and S-phase with an 
increase of cells in G1-phase after 22h and 46h of 5FU treatment (Fig.24A). The 
amount of cells in G2/M-phase was reduced. In contrast, CGR8 cells showed an 
accumulation of cells in S-phase after 46h of 5FU treatment. After 22h an accumulation 
at the G1/S-phase boarder was detected (Fig.24B). As the discrimination between G1- 
and S-phase was difficult in CGR8 cells after PI-staining, due to the high percentage of 
ES cells in S-phase, the experiment was repeated with BrdU-labeling. BrdU is 
incorporated into newly synthesized DNA and therefore marks cells within the S-phase. 
Results 
70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Nuclear localization of p53 in CGR8 and NIH3T3 cells after 5FU treatment. CGR8 (A) 
and NIH3T3 cells (B) were treated with 10µM and 20µM 5FU or DMSO (4µl/ml medium) for 22 hours 
or left untreated. Next, cells were fixed with methanol (CGR8 cells) or methanol/aceton (NIH3T3 
cells) and analyzed by indirect immunofluorescence for p53. Nuclei were counterstained with DAPI. 
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Figure 24: Cell cycle profiles of 5FU-treated CGR8 and NIH3T3 cells analyzed by PI staining. 
NIH3T3 and CGR8 cells were incubated with 10µM and 20µM of 5FU or DMSO (4µl/ml medium) for 
22 hours and 46 hours, respectively, or left untreated. After fixation with EtOH, the DNA content of 
the cells was evaluated with PI staining and FACS analysis. (A) Histograms of cell cycle profiles of 
NIH3T3 cells and quantitative evaluations, indicating the percentage of cells in G1/G0-, S- and G2/M-
phase. Cells with DNA content between 2N and 4N are shown (B) As described in A but for CGR8 
cells. Calculations were performed using the program Cell Quest. 
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Figure 25: Cell cycle profiles of 5FU-treated CGR8 cells analyzed by BrdU labeling. CGR8 cells 
were incubated with 10µM 5FU and DMSO (4µl/ml medium) as control for 24 hours and 48 hours, 
respectively. Cells were labeled for 30 minutes with 10µM BrdU, fixed, stained with an anti-BrdU 
antibody and 7-AAD and analyzed by FACS analysis. (A) Dot blots and respective histograms of 
BrdU and 7-AAD labelled cells with a DNA content between 2N and 4N (B) Quantitative evaluation 
representing the percentage of cells in G1/G0-, S- and G2/M-phase. Calculations were performed 
with Cell Quest. 
 
 
BrdU-positive cells can be subsequently detected by antibody staining and measured 
by FACS analysis. BrdU-labeling showed an accumulation of CGR8 cells in early S-
phase after 24h of 5FU treatment (Fig.25). Cells in G1- and G2/M-phase were reduced 
according to this assay. After 48h, the majority of cells were in S-phase, but the 
intensity of the BrdU incorporation was reduced compared to control cells. 
Nevertheless, the cellular DNA content increased since the measurement after 24h of 
5FU treatment. Hence, it seems that replication still took place, as the large majority of 
cells showed BrdU-incorporation, but it appears to have been hindered. In summary, 
these results support the hypothesis of an impaired p53-p21-Rb pathway in CGR8 cells, 
as was already indicated by the depletion studies with Pes1 and Bop1. Upon 5FU 
treatment, this is additionally reflected by a missing - or at least poorly established and 
only transient - G1-arrest. 
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5 DISCUSSION 
 
 
For efficient proliferation, cells have to coordinate the increase in cell mass with cell 
division. Deregulation of the two processes is involved in a variety of pathological 
conditions like cancer, developmental defects and metabolic disorders. The molecular 
mechanisms controlling the coordination of both processes are still at the onset of 
investigation. Nevertheless, mutual regulations between cell cycle progression (i.e., cell 
division) and ribosome biogenesis (one major factor of cell growth) have been 
described. Embryonic stem (ES) cells display very rapid proliferation, which is slowed 
down during differentiation. Their high proliferation potential is coupled to an unusual 
cell cycle, which lacks a regulated G1/S-phase transition. These specific features are 
strongly suggested to be involved in the maintenance of the self-renewal properties of 
ES cells. In culture, ES cells show an unlimited proliferation potential without being 
immortalized. Moreover, similar to tumor cells, they do not undergo senescence, do not 
show contact inhibition and can grow without serum. Hence, understanding proliferation 
of ES cells will also further shed light on mechanisms involved in self-renewal and 
improve our knowledge about transformed cells. 
During this work, the expression, complex formation and function of the proteins Pes1, 
Bop1 and WDR12, which were shown to play a role in ribosome biogenesis and 
proliferation of mature cells, were examined in ES cells. Thereby, it was aimed to 
investigate the relation of ribosome biogenesis with proliferation, self-renewal and 
differentiation of ES cells.  
 
 
5.1 Nucleolar localization and complex formation as essential factors 
for functionality of Pes1, Bop1 and WDR12  
 
At the initial stages of this work, the expression and physical interaction of murine Pes1, 
Bop1 and WDR12 were investigated in the ES cell line CGR8 and the mouse fibroblast 
cell line NIH3T3. Localization of the proteins was predominantly nucleolar in both cell 
types. In line with this finding, a function of the proteins for rRNA processing during 
ribosome biogenesis was confirmed (see chapter 5.2). Murine Pes1, Bop1 and WDR12 
were shown by native gel electrophoresis to form a stable complex, including all three 
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proteins. Taking a look at the protein structure of Pes1, Bop1 and WDR12 reveals that 
all three proteins contain protein-protein interaction domains.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26: Schematic overview of the protein structures of Pes1, Bop1 and WDR12 and of the 
PeBoW complex. Pes1 contains a highly conserved N-terminal pescadillo-like domain (NPLP-
domain), a BRCT (BRCA1 C-terminal) domain, often involved in protein-protein interactions, and 
three classical nuclear localization signals (NLS). The C-terminus forms a “coiled coil” structure and 
contains two acidic stretches of amino acids, a consensus site for sumoylation (KΨXE) and six 
bipartite NLS. Bop1 contains two PEST sequences, which are often associated with short-lived, 
regulatory proteins, and seven WD40 domains, usually involved in the formation of multiprotein 
complexes. WDR12 contains a Notchless-like (Nle) domain at the N-terminus, a NLS and seven 
WD40 units, which are supposed to form a β-propeller structure. Bop1 is proposed to constitute the 
core component of the PeBoW-complex, interacting directly with Pes1 and WDR12, which itself 
interact only indirectly with each other via Bop1. 
 
 
Pes1 contains a BRCT domain, which is known to facilitate phosphorylation-dependent 
protein-protein interactions. Bop1 and WDR12 contain several WD40 repeats 
respectively, which were also reported to be involved in protein-protein interactions and 
in the formation of multiprotein complexes. Mutations in the WD40 domains of human 
WDR12 and the BRCT domain of human Pes1 caused aberrant cytoplasmic and 
nucleoplasmic localization and instability of the proteins, thereby arguing for a defect in 
complex formation upon loss of those domains (Grimm et al., 2006; Haque et al., 2000; 
Holzel et al., 2007; Holzel et al., 2005; Strezoska et al., 2000; Strezoska et al., 2002). 
Hence, the structural properties of the proteins are in support of the detected complex 
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formation. Further, our results are in consistency with the described complex formation 
of the human homologues of Pes1, Bop1 and WDR12 (Holzel et al., 2005; Rohrmoser 
et al., 2007). Whether the complex, detected by native gel electrophoresis, contains 
additional proteins cannot be excluded, but the fact that stringent conditions for the 
identification of stable core complexes were used for cell lysis would argue against 
additional components, which would be expected to bind less stringently. In yeast, a 
potential homologue of the PeBoW-complex was shown to constitute the core of a 
bigger complex, involving a variety of other factors, the majority of which is related to 
ribosome biogenesis, replication and cell cycle regulation (Du and Stillman, 2002; Miles 
et al., 2005). In mammals such a complex could not be detected so far. However, our 
data do not exclude this possibility as other proteins may bind in vivo, but less 
stringently or under specific circumstances. 
Recent results in our lab revealed that complex formation of human Pes1, Bop1 and 
WDR12 is an important parameter in the stability and functionality of the proteins. It 
seems that Bop1 is the core component of the complex, interacting directly with Pes1 
and WDR12, while Pes1 and WDR12 interact indirectly with each other via Bop1. Free 
proteins seem to be highly unstable (Rohrmoser et al., 2007). The results obtained 
during this work further strengthen this notion since they show a similar behavior of the 
murine proteins, as no free Pes1 or Bop1 proteins were observed by native gel 
electrophoresis. Only murine WDR12 showed a substantial amount of free protein, 
indicating an additional function of WDR12, independent of incorporation into the 
PeBoW-complex. This was not observed at such intensities in human cell lines. Further, 
interdependency of the protein levels of murine Pes1 and Bop1 was observed. 
Depletion of Pes1 by siRNA technology also reduced protein levels of Bop1 and vice 
versa, indicating instability of free proteins. The effect of Pes1 depletion on the 
reduction of Bop1 was stronger, suggesting that non-incorporated Bop1 is the most 
instable one of the three proteins in free form. In accordance with this observation, 
Bop1 contains two PEST motifs, a domain, which is often found in short-lived proteins 
with a regulatory function (see Fig.26). Integration of Pes1 into the PeBoW-complex 
may mask these domains, thereby increasing the stability of the protein. Further, in 
human cells, instability of the free proteins was shown to be independent of 
transcriptional regulation, which argues for a regulation by protein destabilization and 
induced turnover (Rohrmoser et al., 2007). 
In contrast to the interdependency of murine Pes1 and Bop1, there was hardly an effect 
on the levels of murine WDR12 after depletion of Pes1 or Bop1. This observation is in 
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line with the high amounts of free protein detected by native gel electrophoresis and 
further strengthens the hypothesis of an additional function of murine WDR12. A 
biological function of WDR12 independent of ribosome biogenesis and proliferation has 
not yet been elucidated. Ubiquitous expression of its mRNA during embryogenesis may 
indicate an additional function during development. Moreover, large amounts of mRNA 
were found in the thymus and testis of adult mice. An interaction with Notch1-IC, 
revealed by GST-pulldown experiments, further indicates a role in early T-cell 
differentiation (Nal et al., 2002). Indirect immunofluorescence analysis during this work 
gave evidence for a weak cytoplasmic localization of WDR12 in CGR8 cells compared 
to NIH3T3 cells. This may suggest an additional role for WDR12 in early embryonic 
development.  
Complex formation of Pes1, Bop1 and WDR12 seems to be not only a prerequisite for 
their stability, but also for nucleolar localization and incorporation into preribosomal 
complexes and hence for their function. Experiments with several mutants of Pes1 or 
WDR12 had revealed that all dominant negative mutants integrated into the complex 
and located within the nucleoli. They are supposed to achieve a dominant negative 
phenotype by building dead end complexes. Overexpression studies have further 
revealed that human Bop1 needs the help of Pes1 for translocation into the nucleolus, 
while WDR12 is suggested to assemble within the nucleolus with Pes1 and Bop1 to the 
PeBoW complex (Grimm et al., 2006; Holzel et al., 2005; Lapik et al., 2004; Rohrmoser 
et al., 2007). 
In summary, the results obtained in this work present for the first time experimental 
evidence for the formation of a stable complex of Pes1, Bop1 and WDR12 in mouse 
cells and embryonic stem cells. Unlike the situation in human cells, a large amount of 
free WDR12 was present. Generally, the data strongly indicate a similar complex 
assembly in mouse and in human cells, with Bop1 constituting the core component. As 
Bop1 protein seems to be highly instable in its free form, the regulation of Bop1 may 
provide a good target for the fine-tuning of the activity of the PeBoW-complex. In 
addition to the regulation of mRNA levels of Pes1, Bop1 and WDR12 by c-Myc, this 
may account for a second regulatory mechanism linking complex stability and activity to 
the rate of ribosome biogenesis. A possible additional function for WDR12 needs further 
investigation. Except for a weak cytoplasmic staining of WDR12 in CGR8 cells, no 
differences were observed regarding stability, localization and complex formation of 
Pes1, Bop1 and WDR12 between ES cells (CGR8) and the fibroblast mouse cell line 
NIH3T3. 
Discussion 
77 
5.2 Function of Pes1, Bop1 and WDR12 in ES cells and the relation to 
self-renewal and differentiation 
 
5.2.1 Role of Pes1 for nucleologenesis and ribosome biogenesis during early 
embryonic development 
 
Ribosome biogenesis plays an important part already during the early onset of 
embryonic development. Maternally inherited ribosomes are exhausted during the first 
three cleavages of the zygote and the first rDNA transcription is proposed to take place 
between the 2-4-cell stage of mouse development. An increase in ribosome biogenesis 
was observed at the 6-8-cell stage of the embryo (Geuskens and Alexandre, 1984; 
Hillman and Tasca, 1969; Hyttel et al., 2000; Kopecny et al., 1995). This is again 
accelerated during gastrulation, associated with a huge increase in proliferation. Mean 
generation times as short as 4.4h are estimated in the epiblast at this stage (Snow, 
1977; Hogan et al., 1994). In parallel, the nucleolus develops from nucleolar precursor 
bodies, which start to assemble from the 2-cell stage onwards. The typical nucleolar 
architecture with a central fibrillar component, containing proteins involved in rDNA 
transcription, a dense fibrillar component, containing newly synthesized rRNA, and a 
granular component, consisting of preribosomal particles, starts to be visible by electron 
microscopy between the 8-cell and the blastula stage.  
Studies with Pes1 knockout mice revealed an arrest of the preimplantation embryos at 
the morula stage, showed impaired formation of nucleoli, and an inhibited accumulation 
of ribosomes, indicating a function for Pes1 in nucleologenesis and ribosome 
biogenesis (Lerch-Gaggl et al., 2002). The complex formation of Pes1, Bop1 and 
WDR12, which was validated during this work in ES cells, suggests a comparable 
function for Bop1 and WDR12 during early embryonic development and hence an 
essential role for proliferation and survival of the embryo. Recently, also other nucleolar 
proteins were shown to be essential factors for proliferation and embryonic 
development. For instance, embryos depleted for the nucleolar proteins SURF6 or Bysl, 
both involved in the maturation of the small 40S ribosomal subunits, arrest at the 8-cell 
morula stage or just before blastocyst formation (Adachi et al., 2007; Romanova et al., 
2006). Furthermore, Nucleostemin deficient embryos died around embryonic day 4. 
Nucleostemin is a putative GTPase expressed in the nucleoli with a predicted function 
in ribosome biogenesis (Beekman et al., 2006).  
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5.2.2 Function of Pes1, Bop1 and WDR12 for rRNA maturation and proliferation 
of ES cells 
 
During this work, the functions of Pes1, Bop1 and WDR12 were examined in an ES cell 
line in vitro. High expression levels of the proteins Pes1, Bop1 and WDR12 were 
detected in the mouse embryonic stem cell line CGR8, which were strongly reduced 
during differentiation of the cells. In accordance with the nucleolar localization of the 
proteins, a function for Pes1 and Bop1 during ribosome biogenesis was confirmed in ES 
cells. WDR12 could not be investigated due to non-functional siRNAs. The observed 
incorporation of WDR12 (at least partially) into PeBoW-complexes indicates a similar 
function for WDR12. Pes1 and Bop1 were shown to be involved in the maturation of the 
large 60S ribosomal subunit of ES cells. Their depletion led to an impaired maturation of 
the 28S rRNA, while the 18S rRNA, which is part of the small 40S subunit, was not 
affected. Mechanistically, Pes1 and Bop1 seem to be involved in processing events of 
the internal transcribed spacers 1 and 2 as an increase in 36S rRNA and a decrease in 
maturation of 28S rRNA was observed. These results are comparable to effects 
detected in the mouse cell line NIH3T3, which was investigated in parallel, and also to 
previous data obtained in other mature mammalian cell lines (Grimm et al., 2006; Holzel 
et al., 2005; Lapik et al., 2004; Strezoska et al., 2002). Thereby, our data support the 
view of an evolutionary conserved function of Pes1, Bop1 and WDR12 in ribosome 
biogenesis. In addition, a function of Bop1 and Pes1 for 5.8S rRNA maturation and 
processing of the 3’ETS was described in mature cell lines (Lapik et al., 2004; 
Strezoska et al., 2002). These steps were not investigated in this work, but are likely to 
be processed in a similar way in ES cells. 
In addition to the effect on rRNA processing, proliferation of ES cells was hindered upon 
depletion of Pes1 and Bop1. The consistent outcomes between depletion levels and 
either rRNA processing or proliferation rates strongly imply a close link of both 
processes in ES cells, as documented in other cell types. Whether there exists a direct 
crosstalk between ribosome biogenesis and cell cycle control or whether impaired 
proliferation may just be an effect of a depleted ribosome pool is discussed in 
chapter 5.3. 
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5.2.3 Regulation of Pes1, Bop1 and WDR12 during differentiation 
 
The rapid proliferation of ES cells is associated with an unusual cell cycle distribution, 
with the majority of cells detected in S-phase cells and only a short G1-phase. 
Concordant with this, Cdks show constitutive activity throughout the cycle, except for 
the mitotic kinase Cdk1/cyclinB1. Moreover, although the pocket proteins Rb and its 
close homolog p107 are expressed in ES cells, they are constitutively phosphorylated 
and therefore inactivated during the cell cycle, probably due to the cell cycle-
independent activities of the Cdk2- and Cdk6/cyclin complexes. This leads in turn to a 
constant activity of the transcription factor E2F and allows direct S-phase entry without 
the control mechanism usually known as G1/S-phase checkpoint (Savatier et al., 1994; 
Stead et al., 2002). During in vitro differentiation of ES cells, their proliferation slows 
down and the length of the G1-phase increases substantially (White et al., 2005). At the 
molecular level, this is associated with the establishment of cell cycle regulated Cdk2 
activity and the activation of a functional Rb-E2F pathway. Transcription of cyclin E and 
cyclin A is downregulated and their levels become periodically regulated during the 
cycle. Moreover the Cdk-inhibitors p21 and p27 are upregulated, which may also be 
important for the loss of Cdk2 activity during differentiation. 
These changes within the cell cycle control-mechanisms at the beginning of 
differentiation, together with slower proliferation, argue for a lower rate of ribosome 
biogenesis to adjust the supply of ribosomes to the actual demand. In accordance with 
this hypothesis, protein levels of Pes1, Bop1 and WDR12 strongly decreased during 
differentiation from day 6 onwards. Interestingly, the phosphorylation pattern of Rb also 
showed a switch at the same day to the predominant presence of its active, hypo-
phosphorylated form. Thus, the time, when the cell starts to activate a functional Rb-
E2F pathway and thereby also an active G1/S-phase checkpoint, seems to be 
correlated with a reduced rate of ribosome biogenesis. According to the mRNA levels of 
the gastrulation marker T-bra, which showed specific upregulation at day 3-4 of 
differentiation, day 6 corresponds to an early differentiation stage post gastrulation. 
Moreover, at this time, the investigated pluripotency-markers Oct4, Nanog, Sox2 and 
KLF4 were almost undetectable, while upregulation of Flk1 indicates differentiation of 
early mesodermal cells. Whether the changes within the cell cycle are a prerequisite for 
reduced ribosome biogenesis or vice versa remains to be elucidated. In mature cells, 
ribosome biogenesis is cell cycle controlled and sensitive to nutrient and growth factor 
signaling. The formation and maintenance of functional nucleoli during interphase is 
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dependent on Cdk activities (Sirri et al., 2002) and rRNA synthesis largely relies on the 
availability of nutrients and growth factors. Deprivation of the latter or extra- and 
intracellular stresses can lead to downregulation of rRNA synthesis by inhibition of 
Polymerase I (Pol I) via inactivation of the regulatory factor TIF-IA, which abrogates the 
formation of the transcription-initiation complex (Mayer et al., 2005; Mayer et al., 2004). 
Furthermore, G1-phase specific Cdk/cyclin complexes are involved in the 
phosphorylation and activation of the upstream binding factor (UBF), an activator of 
RNA Pol I (Voit et al., 1999). On the other hand, functional ribosome biogenesis is 
essential to keep levels of the tumor suppressor p53 down, thereby ensuring 
proliferation. Disruptions in the structure or function of the nucleolus can inhibit the cell 
cycle - for example by inducing p53 (Pestov et al., 2001; Rubbi and Milner, 2003). Thus, 
mutual regulations of both processes might be another reason behind the changes 
occurring during early differentiation of ES cells.  
Surprisingly, during the first two days of differentiation, an increase in the overall 
amount of Rb was observed, which was reduced again at day 3 of differentiation. 
Nevertheless, the ratio between active and inactive Rb (hypo-phosphorylated Rb to 
hyper-phosphorylated Rb) was not changed. The function of this increase remains so 
far elusive. Active Rb plays also a role for the differentiation of distinct lineages, for 
instance myogenesis, cardiogenesis or adipogenesis, where it is involved as a 
coregulator of transcription factors like MyoD, myogenin or C/EBP (Chen et al., 1996; 
Gu et al., 1993). Thus, the cells might induce total Rb levels to be prepared for further 
differentiation, to switch rapidly to the active form. The downregulation of total Rb levels 
at day 3 of differentiation argues against this assumption though. Another hypothesis 
might be that the cells slightly reduce their proliferation due to the small increase in the 
active form of Rb. In addition to its negative regulation of G1/S-phase transition, active 
Rb can also negatively regulate polymerase I transcription and thereby also regulates 
rRNA transcription. A slight reduction in proliferation might be important for an initial 
step in differentiation. It was hypothesized that the constitutive transit through G1-phase 
could constrain the temporal opportunity for chromatin remodeling or the establishment 
of heritable transcription programs (Burdon et al., 2002). Generally, the gastrulation 
phase of embryonic development is characterized by an increase in cell proliferation. 
During in vitro differentiation a decrease in Rb levels was observed at day 3/4, together 
with induction of the gastrulation marker T-bra, indicating accelerated proliferation of 
differentiating ES cells at this time. Interestingly, an auto-regulation of the Rb gene 
expression is described. The promoter of the Rb gene is transactivated by the 
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transcription factor E2F-1. This leads to an increase in Rb protein, which in its active 
form binds and inhibits the E2F-1 transcription factor and thereby its own expression 
(Shan et al., 1994). Thus, the weak increase in active Rb at day 1 and 2 of 
differentiation might be involved in the decrease at day 3/4. 
Triple knockouts of the three related pocket proteins Rb, p107 and p130 in ES cells do 
not compromise ES cell proliferation, but impair their differentiation capacity in 
teratocarcinomas (Dannenberg et al., 2000; Sage et al., 2000). In contrast, triple 
knockout mouse embryonic fibroblasts (TKO MEFs) were insensitive to senescence 
inducing signals, had an increased proliferation rate and failed to arrest in G1-phase at 
confluency (Sage et al., 2000). This behavior is reminiscent of ES cells. Mice deficient 
for Rb are non-viable and show defects in neurogenesis and hematopoesis. Although 
the pocket proteins seems to have no function for proliferation of ES cells, Rb and p107 
are still expressed, but present mainly in their inactive form. This was hypothesized to 
render ES cells susceptible for a fast switch to differentiation (Burdon et al., 2002). 
Alternatively, one may hypothesize that a rapid activation of Rb might be involved in cell 
cycle arrest after distinct cellular stresses. This was not confirmed during this work (see 
below). Nevertheless, nucleolar stress induced total levels of Rb in a similar manner as 
during early differentiation.  
 
 
5.2.4 The PeBoW-complex and self-renewal 
 
The maintenance of pluripotency during self-renewal of ES cells is proposed to be 
dependent on the prevention of differentiation and the promotion of proliferation (Niwa, 
2007). Evidence for this assumption is given by certain factors and pathways, which 
have an overlapping function in both processes. One important pathway involved in 
proliferation, survival and self-renewal of ES cells is PI3K signaling. Inhibition of PI3K 
and Akt, a downstream effector of PI3K, induces differentiation in the presence of LIF, 
whereas artificial activation of Akt is sufficient to maintain self-renewal in the absence of 
LIF (Paling et al., 2004; Watanabe et al., 2006). Blocking of PTEN, an inhibitor of PI3K-
signaling leads to enhanced proliferation and viability (Sun et al., 1999). PI3K is 
activated by LIF and additionally by two endogenous modulators, which are specifically 
expressed in ES cells. These are Eras, a constitutively active form of the Ras-family, 
and Tcl, which augments Akt by forming a complex with it (Takahashi et al., 2003a; 
Takahashi et al., 2005). Generally, PI3K signaling is implicated in many cellular 
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processes including metabolism, cell cycle progression, survival, migration and 
adhesion. In ES cells, it was reported to play a role in cell cycle progression by 
regulating cyclin D, and in the phosphorylation of ribosomal S6 proteins, which implies a 
role in ribosome biogenesis (Jirmanova et al., 2002; Paling et al., 2004). Hence, PI3K 
signaling may link the short cell cycle of ES cells with self-renewal.  
As Pes1, Bop1 and WDR12 seem to be essential factors for the high proliferation of ES 
cells, the question arises whether the PeBoW-complex might also be involved in the 
maintenance of pluripotency. One could envision that the PeBoW-complex may be 
indirectly linked to the maintenance of pluripotency by regulating proliferation via 
ribosome biogenesis. The expression of Pes1, Bop1 and WDR12 is regulated by the 
proto-oncogene c-Myc (Holzel et al., 2005). The transcription factor c-Myc is known as 
a major coordinator of many cellular processes including ribosome biogenesis and cell 
cycle progression. Recently, c-Myc was shown to be a major factor involved in the 
maintenance of pluripotency, acting downstream of LIF and Stat3 and probably 
downstream of the Wnt signaling pathway (Cartwright et al., 2005). Those are the major 
pathways involved in self-renewal of ES cells in vitro and c-Myc was proposed to 
support self-renewal by inhibition of differentiation. The function of c-Myc as 
transcription factor involves chromatin remodeling and modification processes. 
Overexpression of c-Myc, together with Oct4, Sox2 and KLF4, was crucial for 
de-differentiation of somatic cells into ES-like cells, including remodeling of the 
chromatin to an ES cell-like state (Wernig et al., 2007). This indicates that the role of c-
Myc for self-renewal may include the maintenance of an ES cell chromatin status. By 
activating the expression of Pes1, Bop1 and WDR12 in ES cells, c-Myc might indirectly 
coordinate proliferation with the repression of differentiation, thereby linking both 
processes. In accordance with the function of c-Myc for self-renewal, high levels of 
c-Myc are present in ES cells, but are rapidly downregulated at the beginning 
differentiation within 36h following LIF withdrawal (Cartwright et al., 2005). mRNA levels 
of c-myc decrease rapidly and the protein becomes phosphorylated on threonine 58, 
triggering its GSK3β-dependent degradation. Inactivation of c-myc transcriptional 
regulators, and activation of pathways required for its degradation are proposed to 
define a point of no return, where cells become committed to differentiate. 
Although Pes1 and Bop1 were shown during the course of this work to be essential for 
proliferation of ES cells, first results argue against induction of differentiation after their 
depletion and thus against a role for the maintenance of pluripotency. The transcription 
factors and pluripotency genes Nanog, KLF4 and Sox2 were not significantly 
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downregulated after depletion of Bop1 compared to control cells. Moreover, alkaline 
phosphatase staining and morphology of the colonies did not change significantly, 
indicating that the majority of the cells remained in the undifferentiated state with no 
increase in differentiating colonies. This may suggest that inhibition of ribosome 
biogenesis and proliferation alone do not lead to differentiation. Alternatively, the effect 
achieved on rRNA maturation by depletion of Pes1 or Bop1 might not be strong enough 
to overcome self-renewal. Interestingly, after depletion of the protein Bysl in ES cells, 
which is involved in maturation of the 40S ribosomal subunit, there was also no change 
in the expression of pluripotency markers observed (Adachi et al., 2007). Moreover, it 
was mentioned that inhibition of mTOR inhibited proliferation of ES cells, but did not 
induce differentiation (Watanabe et al., 2006). mTOR is a critical downstream effector 
for the PI3K/Akt signaling pathway with a major function in the regulation of ribosome 
biogenesis. Further experiments are necessary, however, to clarify if the regulation of 
ribosome biogenesis plays a role in self-renewal. 
 
 
5.3 Crosstalk between ribosome biogenesis and cell cycle machinery 
in mouse embryonic stem cells 
 
As indicated before, ribosome biogenesis is an important factor for cell growth needed 
to supply the components for the translational machinery. Doubling of this machinery is 
essential for continuous proliferation to ensure equilibrium between growth and division. 
Increasing evidence points towards mutual regulations of both processes. In mature 
cells, impaired ribosome biogenesis was, for instance, shown to activate a p53-
dependent checkpoint via upregulation of the Cdk-inhibitor p21, which in turn inhibits 
Cdk/cyclin complex activities, which leads to activation (hypo-phosphorylation) of Rb 
and thereby to an arrest of cells in G1-phase (Grimm et al., 2006; Holzel et al., 2005; 
Pestov et al., 2001). Based on the different cell cycle kinetics of ES cells, which do not 
show a G1/S-phase checkpoint during normal proliferation, we were interested to ask 
whether ribosomal stress may activate such a checkpoint in ES cells, thereby linking 
ribosome biogenesis actively with cell cycle progression. After a block of ribosome 
biogenesis, one can generally envisage two scenarios. Either the cells actively adapt to 
the situation by stopping or slowing down their division rate. This can be regulated, for 
instance, due to checkpoint mechanisms, which function as sensor for ribosomal stress, 
as it was indicated for the p53-dependent activation of the G1/S-phase checkpoint. 
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Alternatively, if these mechanisms are not functional, division of the cells will continue 
initially unaltered until the progressive depletion of ribosomes upon each cell division no 
longer allows further proliferation.  
To address the question whether ribosomal stress might induce a p53-dependent 
checkpoint in ES cells, knockdowns of Pes1 and Bop1 were used to inhibit rRNA 
maturation without a genotoxic effect. During the experiments, it turned out that the 
effects observed after Pes1 and Bop1 depletion were not as strong as expected, 
showing a reduction of nascent 28S rRNA levels up to about 50%, but no complete 
block of maturation. This might be explained by the transient transfection of siRNAs and 
therefore a transient knockdown. Transfection with an eGFP-reporter plasmid indicated 
a transfection efficiency of about 70%. This means that at least 30% of the cells might 
not be reached by transfection and will continue to proliferate normally. Thereby, they 
might rapidly overgrow transfected, growth-retarded cells. The chemotherapeutical 
agent 5-Fluorouracil (5FU) was included in the experiments to induce a more potent 
inhibition of ribosome biogenesis. 5FU was reported to mainly inhibit ribosome 
biogenesis if applied at low concentrations (Gilkes et al., 2006). Nevertheless, 5FU is a 
pleiotropic factor whose function is not fully understood and high concentrations of 5FU 
also exert an inhibitory effect on DNA metabolism. 
 
 
5.3.1 Effects of ribosomal stress (5FU) in the mature mouse cell line NIH3T3 
 
To investigate checkpoint activation upon 5FU in a mature cell line, NIH3T3 fibroblasts 
were used. Treatment with 5FU resulted in an accumulation of cells in the G1- and S-
phase, with an increase of cells in G1-phase. The entry of cells into the G2/M-phase 
seemed to be blocked, as the amount of cells with a DNA content of 2N was reduced. 
Protein levels of the Cdk-inhibitor p21 were strongly induced as well as the hypo-
phosphorylated, active form of Rb. This gives strong evidence that p21 inhibits the 
activity of Cdk2/cyclinE complexes, which in turn leads to reduced Rb phosphorylation 
and thus to an increase in active, hypo-phosphorylated Rb. As active Rb binds the 
family of E2F transcription factors, which play a crucial role in progression of cells from 
G1-phase into S-phase, the observed increase in active Rb is most likely the 
responsible factor for the accumulation of cells in G1-phase. In addition, p21 induction 
might also account for the accumulation of cells in S-phase and the decrease of cells in 
G2/M-phase, since p21 can inhibit S-phase progression by binding to PCNA, a subunit 
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of the DNA polymerase δ (Flores-Rozas et al., 1994; Waga et al., 1994). Alternatively, 
other mechanisms could be involved in the decrease of cells in G2/M-phase. Strikingly, 
the levels of p53 showed only a very weak induction, mainly observed by 
immunofluorescence. This may give evidence for a defect in the p53 gene in those 
cells. However, only a weak induction of p53 protein was reported also after disruption 
of ribosome biogenesis with a dominant negative mutant of Bop1 in another NIH3T3 cell 
line. Nevertheless, in this study a p53-dependent induction of p21 as well as G1-arrest 
was confirmed according to p53 inhibitor studies, which attenuated the observed effects 
(Pestov, et al., 2001). So the weak induction of p53 may be responsible at least for part 
of the p21 induction. Alternatively, p53-independent mechanisms for the induction of 
p21 are reported in literature (Aliouat-Denis et al., 2005; Huang et al., 2006; Kim et al., 
2000; Macleod et al., 1995; Serfas et al., 1997; Zeng and el-Deiry, 1996). Mice, 
deficient for p53, are viable, but are predisposed to a variety of tumors by 6 months of 
age (Donehower et al., 1992), whereas mice lacking p21 are defective in G1-checkpoint 
control, but they undergo normal development (Deng et al., 1995).  
Overall, the observed results reflect the notion that ribosomal stress can activate a 
checkpoint, which involves p53, p21 and subsequent activation of Rb, which finally 
leads to an arrest of cells in the G1-phase. 
 
 
5.3.2 Effects of ribosomal stress in ES cells 
 
5.3.2.1 Effects on p53, p21 and Rb upon 5FU and depletion of Pes1 and Bop1 
 
A massive increase of p53 protein was observed in ES cells upon knockdown of Pes1 
or Bop1 and after 5FU treatment. Although p53 was localized in the nucleus, no 
induction of its target gene p21 was observed. In contrast, the overall amount of Rb was 
highly increased, but the ratio between hyper-phosphorylated and hypo-phosphorylated 
Rb did not change towards the active form. This implies that the activities of Rb-kinases 
are not inhibited, due to the fact that no p21 inhibitor is expressed. Hence, the p53-p21-
Rb pathway seems to be inoperative in ES cells after inhibition of ribosome biogenesis. 
These data are in line with publications, showing that Rb is constantly inactive (hyper-
phosphorylated) during normal proliferation of ES cells and that neither contact 
inhibition nor serum deprivation appear to affect proliferation (Savatier et al., 1994; 
Schratt et al., 2001). Moreover, inability of p53 to induce p21 was reported after DNA 
damage. Several DNA damaging agents as well as nucleotide depletion induced p53 
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levels but did not lead to an induction of p21. This was explained by an inefficient 
translocation of p53 into the nucleus, which showed predominantly cytoplasmic 
localization. ES cells were shown to rather undergo apoptosis and accumulate in S- and 
G2/M-phase instead of arresting at G1-phase upon DNA damage (Aladjem et al., 1998; 
Hong et al., 2006; Hong et al., 2007; Hong and Stambrook, 2004). In that context, it was 
supposed that a missing G1-arrest might favor apoptosis, thereby ensuring genome 
stability of the ES cell population. During this work, no major increase in apoptosis was 
observed upon ribosomal stress. Moreover, p53 was located mainly in the nucleus, 
indicating other reasons for the deficit in p21 induction. One explanation might be that 
p53 is not transcriptionally active despite its nuclear localization. However, recent data 
indicate upregulation of numerous p53 target genes after cisplatin treatment of ES cells 
(Kruse et al., 2007). Another alternative for the lack of p21 induction might be that p21 
is transactivated by p53 in ES cells, but the protein is rapidly degraded. The very weak 
levels of p21, which could be detected in 5FU-treated cells compared to control cells, 
may favor this hypothesis. Moreover Malashicheva et al. reported increased p21 protein 
levels upon treatment of ES cells with gamma-irradiation, adriamycin and nocodazol 
after the addition of the proteasome inhibitor lactacystin (Malashicheva et al., 2002). A 
third explanation might be inaccessibility of the p21 gene promoter.  For instance, c-Myc 
was reported to be involved in the methylation of the p21 gene promoter. Together with 
the DNA binding factor Miz-1, it targets the methyltransferase Dnmt3a selectively to the 
promoter of p21 (Brenner et al., 2005). As c-Myc is highly expressed in ES cells this 
could be another possibility. Overall, the observed deficit in p21 induction does not 
exclude the possibility that p53 might fulfill other functions upon ribosomal stress. 
 
In mature cells, induction of p53 upon nucleolar stress is a common feature, which is 
described in several cases to be regulated by free ribosomal proteins. Such a 
mechanism is also described for 5FU. Inhibition of rRNA biogenesis by low 
concentrations of 5FU leads to a deficit of mature rRNAs and thereby to an excess and 
release of free ribosomal proteins, like L5, L11 and L23 (Sun et al., 2007). Those were 
detected to interact with Mdm2, an E3 ubiquitin ligase, which usually binds and targets 
p53 for degradation. Binding of the ribosomal proteins to Mdm2 inhibits the 
ubiquitylation of p53 by Mdm2, leading to stabilization and activation of p53. As we 
could observe reduced levels of mature rRNA species after Pes1 and Bop1 depletion, 
as well as after 5FU treatment, a similar mechanism for p53 induction seems likely in 
ES cells. Alternatively, the so-called “riding the ribosome” model has been proposed as 
another possibility for p53 stabilization in response to ribosomal stress. This model 
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postulates an export of p53-Mdm2 complexes into the cytoplasm via association with 
pre-ribosomal particles. During functional ribosome biogenesis, a high amount of pre-
ribosomal particles is transported into the cytoplasm for their final maturation into 
ribosomes. Therefore, the cell has enough capacity to cotransport p53 into the 
cytoplasm, where it is degraded, and keeps the p53 level low. During disturbed 
ribosome biogenesis, maturation and export of pre-ribosomal particles are diminished 
and therefore also the export of p53, which accumulates in the nucleus (Sherr and 
Weber, 2000). Evidence for this model is given by the observations that p53 
accumulated in the nucleus after inhibition of nuclear export. Moreover, p53 was found 
to covalently bind to the 5.8S RNA, and p53-Mdm2 complexes were detected together 
with the ribosomal proteins L5 and L11 (Fontoura et al., 1997; Marechal et al., 1994). 
Generally, Mdm2 is expressed in mouse ES cells (Ginis et al., 2004) and seems to be 
an important negative regulator of p53. Mdm2 null mice die during early embryonic 
development before day 5.5 and consist only of few cells. This phenotype was rescued 
by additional deletion of p53 (Jones et al., 1995; Montes de Oca Luna et al., 1995). 
 
The reason for the increase in total Rb protein levels upon nucleolar stress remains so 
far elusive, especially as most of the protein remained still in the inactive form and no 
robust G1-arrest was observed (see below). Interestingly, Mdm2 was reported to have a 
function for Rb ubiquitylation and degradation (Miwa et al., 2006; Uchida et al., 2005) 
As we suppose that Mdm2 is inactivated upon 5FU treatment and upon depletion of 
Pes1 or Bop1, due to free ribosomal proteins, this inactivation might also lead to 
stabilization and induction of Rb protein levels. One might speculate that induction of 
total Rb levels is a mechanism to also increase the levels of the hypo-phosphorylated, 
active form, without changes in the activity of Cdks. Cdk2/cyclinE and Cdk6/cyclinD 
activities seem to be the main factors for Rb phosphorylation in ES cells (Faast et al., 
2004). Their activities were not examined during this work, but due to the strong inactive 
(hyper-phosphorylated) fraction of Rb a decrease of their activities seems unlikely.  
 
 
5.3.2.2 Opposing effects on cell cycle distribution of ES cells upon 5FU 
treatment and depletion of Pes1 and Bop1 
 
Effects upon 5FU treatment: 
Although similar effects were observed on p53, p21 and Rb in ES cells upon 5FU 
treatment and depletion of Pes1 and Bop1, opposing effects were detected on the cell 
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cycle distribution. Upon 5FU treatment the majority of CGR8 cells accumulated in S-
phase and no stable G1-arrest was observed. The amount of cells in G2/M-phase was 
reduced and thus the entry into G2/M-phase seemed to be blocked, similar as observed 
in NIH3T3 cells. Whether the accumulation of cells in S-phase is dependent on the 
observed induction of p53 needs further investigation, for example, in a p53 knockout 
ES cell line. In the literature both, p53-dependent and -independent mechanisms for an 
S-phase arrest have been reported, usually after DNA damage (Agarwal et al., 1998; 
Prost et al., 1998; Toyoshima et al., 2005). Interestingly, overexpression of the 
nucleolar protein ARF, which usually stabilizes p53 by binding to Mdm2, can exert a 
delay in S-phase progression, especially if the function of p53 is comprised (Yarbrough 
et al., 2002). Although 5FU was shown to mainly affect RNA-metabolism at low 
concentrations, an additional effect on DNA can not be excluded, especially after longer 
exposure times. Moreover, the relative doses reported to induce certain effects vary 
between different cell types.  
 
Effects upon depletion of Pes1 or Bop1: 
In contrast to an accumulation of cells in S-phase upon 5FU, a weak decrease of cells 
in S-phase and a weak increase in G1-phase was observed upon depletion of Pes1 and 
Bop1. As the p53-p21 pathway seems to not be involved, the underlying mechanisms of 
this effect cannot be fully explained, but the effect might be linked to the slight increase 
in hypo-phosphorylated, active Rb, which was observed together with the increase in 
total Rb levels. For Nop7p, the potential homolog of Pes1 in yeast, a function during 
DNA replication was reported. Nop7p depletion led to an arrest of cells in G1- or G2-
phase, with no cells in S-phase, even if ribosome biogenesis was not impaired (Du and 
Stillman, 2002). In addition, Nop7p was identified as part of a complex, which contained 
also MCM and ORC proteins. One might also hypothesize a function for murine Pes1 
during DNA replication. This in turn might be involved in the weak accumulation of cells 
in G1-phase.  
Generally, the effects observed on cell cycle distribution upon depletion of Pes1 and 
Bop1 seem rather weak to explain the reduced proliferation of the cells. Moreover, no 
strong effect on apoptosis was detected. This suggests the involvement of additional 
mechanisms. In addition to a prolonged G1-phase, cells might perform an overall 
delayed cell cycle progression. For instance, inhibition of Cdk2 kinase activity with a 
specific biochemical inhibitor was reported previously to increase the generation time of 
ES cells without exhibiting a change in cell cycle distribution and without an extension of 
G1-phase (Stead et al., 2002). This indicates that cell division rates are not necessarily 
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coupled to the cell cycle structure and implies a role for Cdk2 in transition through all 
phases of the cycle and not only for the transit from G1- to S-phase (Stead et al., 2002). 
During this work, Cdk activities were not determined as an inhibition seemed unlikely 
due to the strong increase in hyper-phosphorylated Rb and as no induction of p21 was 
observed. Nevertheless, it cannot be completely excluded.  
Another explanation for reduced proliferation and overall slower cell cycle progression 
might be a decreased amount of ribosomes. However, in mature cells no impaired 
translation efficiency was observed after a knockdown of Bop1 (Pestov et al., 2001). In 
addition, other publications reported retarded proliferation, but cells still increased their 
size after impaired ribosome biogenesis (Volarevic et al., 2000). This effect is most 
likely related to a slower G1/S-phase transition, achieved by the reported G1-arrest 
after ribosomal stress, which provides more time for protein synthesis. In contrast, data 
in Rb- and p53-deficient SAOS-2 cells show inability of those cells to arrest in G1- and 
G2-phase after transient ribosomal stress and indicate unchanged cell division. After 
prolonged inhibition of ribosome biogenesis this leads to inhibition of cell proliferation 
due to increased cell death, which was elicited by an insufficient ribosome content 
(Montanaro et al., 2007). In ES cells, Rb was only weakly activated upon nucleolar 
stress and no robust arrest in any cell cycle phase was observed upon depletion of 
Pes1 or Bop1. Thus, a decrease in the ribosome pool due to initially unchanged 
proliferation, which leads to a progressive reduction of the ribosomal content after each 
cell division, cannot be excluded. Pes1 depleted embryos, which arrest at the morula 
stage, showed a strong decrease in ribosomes, but in addition their nucleoli had not 
differentiated normally (Lerch-Gaggl et al., 2002). In our study, a decrease of ribosomes 
as main reason for the impaired proliferation seems unlikely due to the incomplete block 
of rRNA maturation upon Pes1 and Bop1 depletion, which decreased the amount of 
nascent 28S rRNA only to about 50%. Moreover, the lack of major cell death, together 
with the accumulation of cells in S-phase upon 5FU treatment, rather implies that ES 
cells employ active mechanisms to coordinate their cell cycle progression with ribosome 
biogenesis. 
 
5FU versus depletion of Pes1 and Bop1: 
The different effects observed on cell cycle distribution upon 5FU and depletion of Pes1 
or Bop1 might be related to the different intensities of both effectors on ribosome 
biogenesis, with 5FU inducing a much more potent and extensive block (including 18S, 
28S rRNA and some pre rRNAs) as depletion of Pes1 or Bop1, which reduced more 
specifically the maturation of nascent 28S rRNA and those only to about 50%. In 
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addition the pleiotropic function of 5FU, but also additional functions of the PeBoW- 
complex like its indicated function in replication could be involved. In contrast to the 
PeBoW-complex, which is involved mainly in processing steps of the ITS 2, 5FU 
achieves its effects by conversion into 5-fluorouridine-triphosphate, which incorporates 
into rRNA and thereby inhibits processing of rRNA (Sun et al., 2007). In addition 5FU 
can interfere with other RNA species and its conversion into 5-fluoro-dUMP and 5-
flouro-dUTP suppresses DNA synthesis and repair, thereby leading to DNA damage. 
Finally, it has to be considered that mature NIH3T3 cells treated with 5FU also exhibited 
a block in G2/M-phase entry and despite their arrest in G1-phase showed no decrease 
of cells in S-phase. Thus, the accumulation of ES cells in the S-phase upon 5FU 
treatment is not necessarily an ES cell specific response. However, similar upon 5FU 
treatment and depletion of Pes1 or Bop1, no robust G1-arrest was induced in ES cells. 
This seems to be related to the impeded induction of p21. 
 
 
5.3.3 Conclusions 
 
In summary, a function of the PeBoW-complex in ribosome biogenesis of ES cells, and 
a relation to proliferation could be confirmed during this work. Different to mature cells, 
the coordination of ribosome biogenesis with the cell cycle machinery is not regulated 
via the p53-p21-Rb pathway. Nevertheless, the obtained results suggest that ES cells 
employ other mechanisms to coordinate ribosome biogenesis with proliferation. The 
precise nature of these mechanisms needs further investigation. One important 
experiment could be the use of p53-deficient cells, to examine whether p53 is involved 
in such mechanisms, as indicated by its strong induction.  Further, the use of other 
inhibiting agents for ribosome biogenesis like Actinomycin D could be important to rule 
out additional side effects of the used effectors.  
In addition to revealing the coordination of ribosome biogenesis with proliferation of ES 
cells, the question whether ribosome biogenesis is linked to the maintenance of 
pluripotency or whether a defect in ribosome biogenesis just leads to retarded 
proliferation without an effect on pluripotency or differentiation will be of outstanding 
importance in understanding how proliferation and self-renewal are regulated in ES 
cells. 
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6 SUMMARY 
 
The hallmark of embryonic stem (ES) cells is their ability for self-renewal (capability of 
unlimited cell division without the loss of pluripotency) as well as for differentiation into 
all cell types of the adult organism. One factor supposed to be involved in self-renewal 
is the rapid proliferation rate of ES cells, which is coupled to an unusual cell cycle 
distribution with the majority of cells in S-phase and a very short G1-phase. This is 
linked to the lack of a functional G1/S-phase checkpoint, which allows the cells to enter 
the S-phase almost directly after mitosis. Generally, cells have to closely coordinate 
growth and cell cycle progression during proliferation to prevent premature division. 
One important factor for cell growth is ribosome biogenesis. In mature cells, disruptions 
in ribosome biogenesis are directly linked to the cell cycle machinery by a p53-
dependent activation of the G1/S-phase checkpoint, leading to an arrest of cells in G1-
phase. 
During this work, the function of the proteins Pes1, Bop1 and WDR12, which were 
shown previously to be involved in ribosome biogenesis of mature cell lines, was 
investigated in mouse ES cells. Moreover, a putative crosstalk between ribosome 
biogenesis and proliferation of ES cells was assessed. A high expression of Pes1, Bop1 
and WDR12 was observed in ES cells, which strongly decreased during in vitro 
differentiation. Localization of the proteins was predominantly nucleolar and the 
formation of a stable complex (PeBoW-complex), including all three proteins, was 
experimentally validated in mature mouse cells as well as in mouse ES cells. The 
function and stability of the proteins seems to be dependent on incorporation into the 
PeBOW-complex, as protein levels were interdependent on each other and no free, 
non-incorporated proteins were observed, except for WDR12. According to their 
nucleolar localization, depletion of Pes1 and Bop1 were shown to inhibit maturation of 
the 28S rRNA and thereby the large 60S ribosomal subunit. Further, impaired 
proliferation of ES cells was observed. Thus, the PeBoW-complex seems to be an 
essential factor for the rapid proliferation of ES cells and might therefore also be 
involved in self-renewal. However, first results suggest that the complex is not directly 
involved in the maintenance of pluripotency. No changes in the expression levels of 
pluripotency-genes like Nanog, KLF4 and Sox2 were observed. Moreover, alkaline 
phosphatase activity was equally detectable after depletion of Pes1 or Bop1 and no 
morphological changes within the ES cell colonies were observed. 
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Impaired ribosome biogenesis is known to activate a p53-dependent checkpoint in 
mature cell lines, which leads to an arrest of cells in G1-phase. Treatment of mouse 
NIH3T3 cells with 5FU, a potent inhibitor of rRNA maturation, confirmed an activation of 
this checkpoint, leading to weak induction of the tumor suppressor p53, induction of the 
Cdk-inhibitor p21, an increase in active, hypo-phosphorylated Rb, and to accumulation 
of cells in the G1- and S-phase with an increase of cells in G1-phase. In contrast, ES 
cells showed strong induction of p53, but no induction of its target gene p21. The overall 
levels of Rb were strongly induced, but the ratio between inactive, hyper-
phosphorylated Rb and active, hypo-phosphorylated Rb was not changed towards the 
active form. These results were observed upon 5FU treatment and upon depletion of 
Pes1 or Bop1. Hence, ribosomal stress does not lead to checkpoint activation via the 
p53-p21-Rb pathway in ES cells. Moreover, no robust accumulation of cells in G1-
phase was observed. 5FU treated ES cells showed an accumulation of cells in S-phase 
instead. Whether this effect is regulated by the induced p53 needs further investigation. 
Overall, the results suggest that ES cells use different mechanisms as mature cells to 
coordinate their proliferation rate with ribosome biogenesis.  
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8 ABBREVIATIONS 
 
 
α anti / alpha 
β-ME β-mercaptoethanol 
µg microgram 
µl microliter 
µM micromolar 
A adenosine 
aa amino acid 
Ab antibody 
AP alkaline phosphatase 
APS ammonium persulfate 
bp base pair 
BrdU bromodeoxyuridine 
BSA bovine serum albumine 
C cytosine 
C- carboxy- 
Cdk cyclin-dependent kinase 
cDNA complementary DNA 
d day(s) 
DAPI 4,6-Diamino-2-phenylindol 
DEPC diethylpyrocarbonate 
DMSO dimethylsulfoxide 
DNA 2’-deoxyribonucleic acid 
dNTP 3’-deoxyribobucleoside-5’-triphosphate 
dpc days post coitum 
EB embryoid body 
EDTA ethylenediamine tetra-acetic acid 
e.g. for example 
EGFP enhanced green fluorescent protein 
ES cells embryonic stem cells 
EtOH ethanol 
ETS external transcribed spacer 
FACS fluorescence activated cell sorting 
FBS fetal bovine serum 
FITC fluoresceinisothiocyanat 
G guanidine 
GFP green fluorescent protein 
h human, hour(s) 
HRP horseradish peroxidase 
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ICM inner cell mass 
ITS internal transcribed spacer 
kb kilo base pairs 
kD kilo Dalton 
LIF leukemia inhibitory factor 
m murine 
MAPK mitogen activated protein kinase 
MEK mitogen activated kinase kinase 
MEM non-essential amino acids 
min minute(s) 
mM millimolar 
monocl. monoclonal 
MOPS 3-(N-morpholino) propansulfonic acid 
myc myeloblastom 
N- amino- 
nM nanomolar 
PBS Phosphate –buffered saline 
PCR polymerase chain reaction 
PI propidium iodide 
PI3K phosphatidylinositol-3-kinase 
polycl. polyclonal 
pRb hypo-phosphorylated Rb 
ppRb hyper-phosphorylated Rb 
Rb Retinoblastoma gene product 
RNA ribonucleic acid 
RNase ribonuclease 
rpm rounds per minute 
rRNA ribosomal RNA 
RT room temperature / reverse transcription 
SD standard deviation 
SDS-PAGE sodiumdodecylsulfate-polyacrylamide gel electrophoresis 
sec second(s) 
siRNA small interfering RNA 
STAT signal transducer and activator of transcription 
T thymine 
TBS tris-buffered saline 
TE tris-chloride/EDTA (10:1) 
TEMED N,N,N’,N’-tetramethylethylendiamine 
TRIS tris-(hydroymethyl)-ammoniummethan 
U units 
UV ultraviolet 
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